1,2,3-triazoles as X-factor in gold(I) activation of challenging C-C triple bond transformations by Wang, Qiaoyi
Graduate Theses, Dissertations, and Problem Reports 
2014 
1,2,3-triazoles as X-factor in gold(I) activation of challenging C-C 
triple bond transformations 
Qiaoyi Wang 
West Virginia University 
Follow this and additional works at: https://researchrepository.wvu.edu/etd 
Recommended Citation 
Wang, Qiaoyi, "1,2,3-triazoles as X-factor in gold(I) activation of challenging C-C triple bond 
transformations" (2014). Graduate Theses, Dissertations, and Problem Reports. 357. 
https://researchrepository.wvu.edu/etd/357 
This Dissertation is protected by copyright and/or related rights. It has been brought to you by the The Research 
Repository @ WVU with permission from the rights-holder(s). You are free to use this Dissertation in any way that is 
permitted by the copyright and related rights legislation that applies to your use. For other uses you must obtain 
permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license 
in the record and/ or on the work itself. This Dissertation has been accepted for inclusion in WVU Graduate Theses, 
Dissertations, and Problem Reports collection by an authorized administrator of The Research Repository @ WVU. 
For more information, please contact researchrepository@mail.wvu.edu. 
 
 
1,2,3-triazoles as X-factor in gold(I) activation 







Dissertation submitted to the 
Eberly College of Arts and Sciences 
at West Virginia University 
in partial fulfillment of the requirements 










Xiaodong Shi, Ph.D., Chair 
Peter Gannett, Ph.D. 
Jeffrey L. Petersen, Ph.D. 
Björn Söderberg, Ph.D. 
Kung K. Wang, Ph.D. 
 











Keywords: Functional 1,2,3-Triazoles, Transition Metal Catalysis ,  
Iron Chemistry, Allene,BN heterocycle, Triazole-gold complexes 
 






The 'click chemistry' which provides 1,4-disubstituted 1,2,3-triazoles has been reported in 2001. New 
method for highly funtionalized 1,2,3-triazole synthesis becomes very desirable along with the discovery 
of unique properties of this heterocyclic structure. Our group focused on the synthesis of functional 1,2,3-
triazole for several years and new methodologies have been developed such as arylation, vinylation, 
propargylation and allenation. Besides the new methods are benefiting the field related to triazole 
functionalization, new reactivity of ligand-metal complexes was revealed.  
A series of 1,2,3-triazole gold complexes were synthesized/characterized. This dissertation presents 
the results of research effort to explore the unique chemoselectivity and improved thermal stability that 
arises when triazole is introduced as a X-factor or secondary ligand. This effort successfully led to the 
efficient synthesis of traditionally challenging compounds. The benzotriazole modified gold(I) complex 
showed high reactivity toward propargyl ester/vinyl ether. Through a simple 3,3-rearrangement, allene 
derivatives, which were usually considered as intermediate in the gold(I) chemistry, were isolated as a 
major product. The treatment of allene derivatives with triazole gold complex showed no apparent 
decomposition of allene and confirmed the triazole-gold complex could selectively perform the π-acidity 
toward C-C triple bond over allene. With this triazole modification, the thermal stability of the 
corresponding gold(I) complexes is significantly improved. Triazole-gold(I) facilitated alkyne 
hydroboration was accomplished at 80 
o
C, which is a temperature leads to serious complex decomposition 
of previous cationic gold(I) species. Moreover, 
31
P NMR proved the stability of triazole-gold complex 
toward the highly reductive reaction precursor (such as boronhydride). This new strategy enabled an 
efficient method for amine borane heterocyclic structures synthesis, which has been considerable 
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Chapter One: Iron catalyzed C-O bond activation for the synthesis 




The 1,2,3-triazole molecular system, as an interesting heterocyclic structure, has gained a lot 
attention recently.
1
 The 'click chemistry' developed by Sharpless in 2001 provided an efficient 
method to access 1,4-disubstituted 1,2,3-triazoles (Scheme 1).
2
  
Scheme 1. The synthesis of 1,4-disubstituted 1,2,3-triaozles by 'click chemistry'. 
 
Although Cu(I) sources are active in this process, such as copper(I) bromide (CuBr) or 
copper(I) iodide (CuI), the catalyst performs better when it is prepared in situ by the reduction of 
Cu(II) salts (e.g. CuSO4) with reducing reagent such as sodium ascorbate or ascorbic acid 
(Scheme 2). This transformation tolerated a broad substrate scope and produced the 1,4-
disubstituted 1,2,3-triaozles in good to excellent yields with perfect regioselectivity. 




Density functional theory calculations (DFT) were subsequently used to investigate the 
reaction mechanism. In the presence of a base, the acidic terminal hydrogen is deprotonated first 
to give a Cu(I) acetylide complex intermediate. Studies have also shown that in the transition 
state, two copper centers were involved. One copper atom is bound to the acetylide, while the 
other Cu atom serves as Lewis acid to activate the azide by coordinating with the nitrogen atom. 
The azide and the acetylide are then linked together through bridging ligands which are labile 
and weakly coordinating. The azide displaces one ligand (L) to generate a copper-azide-acetylide 
complex (CuAAC). At this point, cyclization occurs and followed by protonation. The product is 
formed by elimination of copper to give the copper complex and the catalytically active copper-
ligand complex is regenerated for maintaining catalytic reaction cycles (Figure 1). 
 
Figure 1. Proposed reaction mechanism of 'Click chemistry'. 
 
Investigations of the application of 1,2,3-triazole as a ligand system was initiated during the 
past decade.
3
 A series of new 1,2,3-triazole metal complexes were synthesized and 
characterized.
4
 To better evaluate this unique heterocyclic structure as a ligand in the transition 
3 
 
metal catalysis for new reactivity, it became apparent that new, efficient synthetic methods were 
needed to prepare a wide range of functionalized triazoles. The initial effort was devoted to the 
preparation of NH-1,2,3-triazoles based on the modification of 'click chemistry' which does not 
permit the use of unsubstituted azides such as NaN3 and HN3. By substituting the azide with 
removable N-protecting groups, the NH-1,2,3-triazoles was first reported through the CuAAC 
intermediate and subsequent deprotection of N in 2005 (Scheme 3).
5
  
Scheme 3. Synthesis of NH-1,2,3-triazoles through CuAAC. 
 
Meanwhile, the 1,3-dipolar cycloaddition between nitroalkene and sodium azide was 
considered as another efficient methodology for the synthesis of NH-1,2,3-triazoles. Because the 
original conditions
6
 could not be reproduced, Zard in 2005 eventually developed the optimal 
conditions, as indicated in Scheme 4, obtained good to excellent yields with minimal formation 
of presumable by-product (such as 1,3,5-triarylbenzene).
7
 
Scheme 4. Thermal condensation of nitroalkene and sodium azide (Zard’s method). 
 
The base-catalyzed cascade nitroalkene-aldehyde-azide condensation for the synthesis of 4,5-
disubstituted NH-1,2,3-triazoles was developed and reported in 2008 by Shi and co-workers.
8
 A 
series of new NH-1,2,3-triazoles was prepared in good to excellent yields under mild conditions 
4 
 
(Scheme 5). The alkene substituent could be easily converted into other functional groups such 
as carbonyl and alkanes. 
Scheme 5. Shi’s approach: Lewis base-catalyzed cascade nitroalkene-aldehyde-azide 
condensation. 
 
Through the investigation of the reaction mechanism, a Henry reaction between nitroalkene 
and aldehyde was considered as the initiation step. Subsequently, the azide addition to the 
nitroalkene intermediate and elimination of the nitro group, formed the desired triazoles as major 
products. The mechanism was indicated in Figure 2.  
 
Figure 2. Mechanism for synthesis of 4,5-disubstituted NH-1,2,3-triazoles. 
 
All the methodologies above provide the access to N-1 and C-4,5 substituted triazoles 
effectively. The N-2 substituted 1,2,3-triazoles have never been reported in the literature before 
2008. Both CuAAC strategy ('click chemistry') and 1,3-dipolar cycloaddition will not provide the 
5 
 
N-2 substituted derivatives mechanistically. On another side, the nature of the triazole ring 
maintains a strong dipole moment and high electron density on the nitrogens. Therefore, the NH-
1,2,3-triazole could be a good nucleophile, which reacts with electrophiles under suitable 
conditions to achieve the N-2 substituted derivatives. This strategy resulted a major concern of 
N-1/N-2 selectivity. All reported cases give N-1 substituted derivatives as predominate products 
through nucleophilic substitution reactions.
9
  
The Shi group focused the effort toward the N-2 regioselective synthesis of 1,2,3-triazoles. 
Because the cascade condensation reaction gives an efficient access to 4,5-disubstitued 
derivatives, the increased steric hindrance from the two substituents is expected to influence the 
regioselectivity which is needed to achieve N-2 substituted derivatives through SN2 addition.
10
 In 










1.2 Research Objective and Results 
The examples highlighted in the previous section completed the synthesis or 
functionalization of substituted 1,2,3-triazoles. With the synthetic 'kit box' to reach different 
functionalized triazoles, investigation of the potential application of 1,2,3-triazole as a ligand 
system in transition metal chemistry was initiated. Some interesting results have been reported in 
literatures regarding metal catalysis with simple 1,2,3-triazoles as ligands.
12
 The fast growing 
research applications of this heterocycle necessitate the development of effective methods for the 
preparation of diverse 1,2,3-triazole derivatives, which can behave as classic bidentate or 
chelating ligand systems.  
Bis-triazole compounds which behave as bidentate ligands could be synthesized through 
nucleophlic addition between NH-1,2,3-triazoles and linking moieties (N-N type bis-triazole), or 
'click chemistry' between bis-alkynes and azide compounds (C-C type bis-triazole). Although, 
these synthetic strategies could effectively prepare bis-triazole compounds, (N-N type
13
, and C-C 
type
14
) all the products are symmetric (Scheme 7A, B).
15
 The asymmetric bis-triazole retro-
synthetic design indicated in Scheme 7C involved a post-triazole propargylation as the key step 
that could achieve a product with reasonable linking distance, based on Baldwin's Rule (5-
member-ring or 6-member-ring are the favored ring sizes when metal atoms are involved after 





Scheme 7. Three different types of bis-triazole compounds. 
 
Although the retro-synthetic design appears straightforward, the actual preparation was much 
more challenging than expected, especially the post-triazole propargylation. In general, the 
propargylation can be challenging since the nucleophiles could potentially attack the triple bonds 
instead of the propargyl position, give corresponding allene intermediates that further convert 
into undesired products (such as Meyer-Schuster rearrangement products). As a consequence, the 
performance of this transformation usually depends on the nature of the substrates (i.e., the 
stability of leaving groups and steric hindrance of alkynes).
16, 17
 Several tested reaction results 







Scheme 8. Challenges in triazole propargylation. 
 
Though simple propargyl bromide 1.2a, triazole propargylation could be achieved in 
excellent yields (Scheme 8A), the non-substituted methylene group eliminated the possibility of 
chirality or enantio-enriched moiety introduction. It is an important potential position to 
introduce the enantio-enriched environment other than chiral functionalized triazoles during 
ligand chirality control. The direct SN2 addition strategy to propargyl substituted alkynes failed. 
For example, reaction between triazole 1.1a and propargyl acetate 1.2b gave no reaction with 
Cs2CO3 as the base. Treating the substrates under harsher conditions (DMSO and stronger base 
NaOt-Bu) led to the formation of complex reaction mixtures with no desired propargyl triazole 
1.3b isolated (Scheme 8B). Moreover, attempts to convert propargyl alcohol 1.4a into propargyl 
tolsylate or halide also failed when classic conditions were applied. This was likely caused by the 
undesired side reactions associated with propargyl-allene decomposition as mentioned 
previously. When appropriate leaving/electron deficient substituted group presented under basic 
9 
 
conditions, the possible deprotonation procedure lead to the formation of corresponding allene 
derivatives and then gave undesired decomposition. 
We therefore deduced that one alternative synthesis of propargyl triazoles could be the C-O 
bond activation of a propargyl alcohol with appropriate Lewis acid presented and followed by 
triazole addition (Scheme 8C). A series of different commonly used Lewis acid catalysts were 
then investigated to evaluate the ability to promote the propargylation of triazole 1.1a and 
propargyl alcohol 1.4a. The results are summarized in Table 1. 











1 FeCl3 20 DCE 60 17 100 90 8:1 
2 Cu(OAc)2 20 DCE 60 17 57 <5 n.d. 
3 CuI 20 DCE 60 17 22 <5 n.d. 
4 PdCl2 20 DCE 60 17 13 <5 n.d. 
5 RuCl3 20 DCE 60 17 69 49 1.1:1 
6 IrCl3 20 DCE 60 17 96 65 2:1 
7 Co(OAc)2 20 DCE 60 17 28 <5 n.d. 
8 LaCl3 20 DCE 60 17 21 <5 n.d. 
9 CeCl3 20 DCE 60 17 30 <5 n.d. 
10 Ti(O-iPr) 20 DCE 60 17 52 <5 n.d. 
11 AlCl3 20 DCE 60 17 26 <5 n.d. 
12 TfOH 20 DCE 60 17 100 35 1.5:1 
13 H3PO4 20 DCE 60 17 73 9 1:1 
10 
 
14 FeCl3 20 THF 60 7 90 70 6:1 
15 FeCl3 20 Toluene 60 7 100 40 2:1 
16 FeCl3 20 MeOH 60 7 60 44 7:1 
17 FeCl3 20 MeNO2 60 7 90 <5 n.d. 
18 FeCl3 20 DMF 60 7 <5 <5 n.d. 
19 FeCl3 20 DMSO 60 7 <5 <5 n.d. 
20 FeCl3 20 MeCN 60 7 91 85 10:1 
21 FeCl3 20 MeCN rt 12 62 50 9:1 
22 FeCl3 20 MeCN 90 5 100 93 11:1 
23 FeCl3 10 MeCN 90 10 100 90 10:1 
24 FeCl3 5 MeCN 90 12 90 82 9:1 
a
 Standard reaction condition: 1 equiv of propargyl alcohols, 1.2 equiv of triazoles, and indicated equiv of 
catalyst were added in order to corresponding solvents. 
b
 Conversions were determined based on the 
consumption of 1.4a. 
c
 Yields determined by NMR with 1,3,5-trimethoxybenzene as the internal standard, 
and ratios determined by NMR of crude reaction mixtures. 
 
Although significant decomposition of 1.4a occurred with most of the Lewis acid catalysts 
(i.e. Entry 2, 10, 12, 13, 17), we observed that FeCl3 was an effective catalyst for promoting this 
transformation and the desired product 1.3b was obtained in good yield (entry 1). Further 
screening revealed MeCN as the optimal solvent (entries 14-20). Comparable yields were 
obtained even with decreased catalyst loading (entries 23 and 24), which is likely due to the 
decreased rate of possible carbon cation decomposition process. With the optimal conditions in 
hand, different triazoles and propargyl alcohols were evaluated to investigate the reaction 




Figure 3. Reaction substrate scope. Yields were determined by NMR with 1,3,5-trimethoxybenzene as 
the internal standard, and ratios determined by NMR of crude reaction mixtures. The N-2 1.3f structure 
was confirmed by X-ray crystallography. 
 
As showed in Figure 3, this Fe(III)-catalyzed propargylation was suitable for various 
different internal alkyne propargyl alcohols, which provided another available methods for 
effective post-triazole functionalization. Similar result was observed comparing to our previously 
reported strategy, the regioselectivity of 1,2,3-triazole strongly depends on the nature of the 
triazole substrate. For example, the benzotriazole gave N-1 regioselectivity, whereas, 
12 
 
predominantly N-2 isomers were obtained when more sterically hindered keto-modified 4,5-
disubstituted triazoles were employed (i.e., 3c, 3g). Meanwhile, when C-4 phenyl triazole was 
treated under the same conditions, a mixture of both N-1 and N-2 regio-isomers in a 1:4 ratio, 
respectively, was obtained. The N-2 substituted derivative 3f was structurally characterized by 
X-ray crystallography (Figure 4).  
 
Figure 4. Perspective view of the structure of C23H17N3 (compound 1.3f). The ball and stick drawing. 
CCDC number: 775267 
 
The substituted groups on the propargyl position were critical for this transformation. The 
reaction generally worked well with aromatic substituted propargyl alcohols, except substrates 
with strong electron withdrawing groups (the p-nitrobenzene gave no reaction). No reactions 
were observed with aliphatic substituted propargyl alcohols. Impressively, the reaction proceeds 
smoothly with vinyl substituted substrate (such as 1.3r), giving the corresponding triazole 
substituted enynes in excellent yields. Notably, Nazarov cyclization products were not observed 
13 
 
in these reactions, which highlighted the rather mild conditions of the reported method. Excellent 
yields were generally received for internal alkynes with different substituted groups, including 
alkyl, aryl, TMS, and cyclopropyl. The reaction was also suitable for terminal alkyne and gave 
the corresponding propargyl triazoles in good yields based on NMR (Scheme 9). Surprisingly, 
substrate 1.3t was not stable upon concentration and gave complex reaction mixtures. This 
interesting transformation is currently under investigation. 
Scheme 9. Unexpected decomposition of terminal alkyne substrates. 
 
 
The unexpected decomposition of terminal alkyne 1.3t raised serious concerns regarding the 
designated 'click chemistry' for the introduction of the second triazole rings. The 'click chemistry' 
is theoretically active only toward terminal alkynes since the copper-azide-acetylide complex 
plays key intermediate in the catalytic cycle. We therefore, tested the TMS derivatives which 




Figure 5. Synthesis of unsymmetrical N-C type bis-triazoles. Isolated yields for all cases. Condition: 0.05 
equiv of CuSO4, 0.1 equiv of sodium ascorbate, BuOH-H2O (1:1), 60 
o
C, 12 h. Structure 1.5g was 
confirmed by X-ray crystallography. 
 
Fortunately, reactions between TMS-alkynes and corresponding azides gave the desired bis-
triazoles (1.5a-1.5h) in excellent yields under standard 'click chemistry' condition (Figure 5).
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Figure 6. Perspective view of the structure of C22H24N6O3 (compound 1.5g). The ball and stick drawing. 
CCDC number: 775268 
 
1.3 Conclusion 
In conclusion, a FeCl3 catalyzed post-triazole propargylation was developed, giving the 
desired propargyl triazole in excellent yields which is a challenging synthesis when using N-2 
nucleophilic substitution or 'click chemistry'. This method presents high efficiency. Application 
of this strategy led to the synthesis of unsymmetrical 1,1-bistriazoles. This study not only affords 
an efficient post-triazole functionalization strategy for the preparation of diverse triazole 
analogues, but also provides entry to a new class of bis-triazole compounds as a bidentate ligand 
system. Application of this type of bis-triazole ligands in transition metal coordination and 






Dr. Wuming Yan and Dr. Yunfeng Chen were the researchers who had first investigated the 
reaction. Together Dr. Yan and Qiaoyi Wang were responsible for the substrate scope evaluation, 
ratio of N-1/N-2 regio-isomers determination and manuscript completion for successful 
submission to Organic Letters. Detailed X-ray crystallographic data analysis of compound 1.3f 
and 1.5g was done by Prof. Jeffrey L. Petersen, C. Eugene Bennett Department of Chemistry, 








Chapter Two: 1,2,3-triazoles work as X-factor to promote gold(I) 




2.1.1 Background information about homogeneous gold catalysis 
 
Homogeneous catalysis with gold complexes emerged as one of the most rapidly developing 
fields in this new century, which is called the 'gold rush'.
19
 Newly discovered transformations 
have furnished numerous synthetic applications in the organic field.
20
 In comparison to the 
traditional transition metal catalysis, gold chemistry presents several advantages: 1) high 
reactivity enables the reactions to occur under mild conditions; 2) high efficiency provides low 
catalyst loading (lower than 1 mol % in some cases); 3) multiple revealed reaction mechanisms 
involved in different reaction patterns increases the product diversity significantly with simple 
reaction precursors. Several representative examples regarding gold catalysis are shown in 








Scheme 10. Recent gold(I) catalyzed transformations. 
 
Besides all the improvement and progress we have achieved, these exciting results revealed 
more questions regarding the process of homogeneous gold catalysis. At the beginning of the 
21th century, gold(III) complexes were assumed to behave as a simple Lewis acid in the reported 
transformations.
21
 Meanwhile, the π-acid activation by gold(I) catalysis was also 
straightforward.
22
 Gold(I) complexes prepared for the chemical transformations are usually 
19 
 
bonded with strong coordinating ligands such as phosphines or NHC carbenes with chloride as 
the counter anion. The key functions for these ancillary ligands are: 1) increasing the solubility 
of the inorganic salt and tuning the reactivity or product selectivity; 2) improving the stability of 
gold(I) complexes during the reaction period toward moisture/air or other effects which could 
cause catalyst decomposition. The later function was considered to be very crucial in the gold(I) 
chemistry since the stability issue was one of the major drawbacks that limited the application of 
this promising metal catalytic system. 
To access the reactivity of gold(I) complex as an efficient soft carbophilic π-acid toward the 
C-C multiple bonds, removal of chloride counter anion was required to generate the 
corresponding cationic gold(I) species. Most of the reported methods for homogeneous cationic 
gold(I) species generation adopted mixing the gold chlorides with silver salts to introduce the 













With the activating species present, a general mechanism involved in most of the gold(I) 
homogeneous catalysis is showed in Figure 7. The opened coordination site complexation 
occurs with C-C multiple bond (C-C triple bond is used for example in Figure 7) in the substrate. 
Then the addition of nucleophile to the activated π-bond occurred and followed by proto 




Figure 7. Classic homogeneous gold(I) catalytic cycle. 
Despite the remarkable reactivity of the cationic gold(I) species, practical disadvantage does 
exist, most notably, a lack of stability under harsh conditions such as an elevated reaction 
temperature or the presence of a reductive nucleophile. These harsh conditions will cause serious 
catalyst decomposition indicated by the formation of gold mirror or gold nanoparticles. As a 
consequence, the gold(I) chemistry needs to be performed under mild conditions with careful 
substrate considerations. 
Efforts have been devoted towards improving the stability of the gold(I) complexes. 
Preliminary results have demonstrated that the stability of the cationic gold(I) species can be 
improved through two general modifications: 1) different coordinating ligands and 2) counter 
ions with better coordination ability. 
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Among the reported systems, the N-heterocyclic carbenes (NHC's) and phos type ligands are 
representative examples in the early stage to improve the gold cation stability through different 
strategies. The NHC's have been applied as ligands in transition metal catalysis for decades
23
 and 
are commonly described as excellent σ-donors which provide them distinctive affinity toward 
metals. Also, the vacant p-orbital provides the possibility of d-electron p-orbital back bonding, 
which improved the ligand coordination and the stability of the metal center. On the other hand, 
phos type phosphine ligands also showed excellent stabilizing ability to gold(I) complexes with 
their unique spatial confirmation.
24
 The steric hindrance introduced after coordinating with Au 
cation blocks one open side along the axis of this linear L-Au-Cl moiety (Figure 8).  
 
Figure 8. IPrAuCl and XPhosAuCl complexes with improved Au cation stability. 
 
2.1.2 'Silver effect' in homogeneous gold(I) catalysis 
 
With different primary ligands, the more stable Au cation complexes enabled the activation 
of some less reactive substrates such as internal alkynes, which usually required a harsher 
condition to reach efficient conversion. New Au complexes that expanded the temperature range 
for gold(I) catalysis could help researchers to overcome the dilemma of reactivity versus stability 
to achieve more desirable substrate tolerance.  
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While the breakthrough has been achieved by innovative primary ligands, a practical issue 
regarding the traditional gold catalysis still remained and limited the improvements for this 
promising metal catalyst, specifically the silver salt. The LAuCl complex is unreactive toward 
most of the substrates such as C-C triple bonds, due to the strong coordination between Au and 
Cl atoms which blocked the ligand exchange process. To remove the chloride, the most common 
method adopted by researchers is the addition of silver salt to form silver chloride precipitation 
and generated the cationic gold species. This method introduced less coordinating counter ion for 
gold which is more suitable for the activation process. It is agreed that the activated gold(I) 
cation - counter ion species are not very stable and need to be prepared before the reaction setup 
or generated in situ. The silver salts are highly hygroscopic and the chemical weighting should 
be taken under a humidity free environment, which usually requires operation in a glovebox. 
Moreover, a very recent result has shown that the newly introduced silver salt to the reaction 
mixture might not form the silver chloride precipitation and be removed very efficiently by 
passing the gold-silver mixture through a cotton plug or filter paper (which is a common method 
that has been applied in recent researches).
25
 The trace amount of silver metal left in the reaction 
mixture together with the substrate is right now been demonstrated to functionalizing as gold-
silver di-metal system in the resting state recently in 2009.
26
 For the first time, this result 
revealed that silver plays a more important role in the reaction pathway other than a simple 






Scheme 11. Different resting states in the gold(I) catalysis when silver is presented. 
 
In Prof. Gagne's result, the resting states of the gold(I) activated Friedel-Crafts reaction 
showed two convertible intermediates 2.3 and 2.4 due to different ratio of gold to silver cations 
(Figure 9A). Although the two intermediates did not affect the overall reaction and gave the 
same product in this very first case, it indeed changes the reaction rate.  
Silver salt involved in the formation of intermediate 2.4, and the excess amount of AgNTf2 





Figure 9. A, Change in catalyst resting state from 2.4 (Au-Ag) to 2.3 (Au-Au) upon additions of 
Ph3PAuNTf2 to a solution of 0.1 mmol 1 and 15.5 mol % AgNTf2 in CD2Cl2; B, ln 2.1 versus time [s] for 
the conversion to 2.2 by 1H NMR; 0.1 mmol 2.1, 5 mol % Ph3PAuNTf2, and 0.05 mmol 
hexamethylbenzene (internal standard) in 0.5 mL CD2Cl2; 6.2 mg (16 mol %) AgNTf2 was added as a 
solid. 
 
One of the gold(I) complexes that has been prepared which could be considered as 'silver 
free' was reported by Prof. Gagosz and co-workers in 2007 with 
bis(trifluoromethanesulfonyl)imidate moiety (Tf2N
-
) as counter ion for gold(I) (Scheme 12A). 
Tf2N
-
 is a weakly coordinating anion which could serve to stabilize gold(I) complex in both the 
solid and solution state.
27
 This more stable property enabled people to perform recrystalization 
and remove the possible trace amount silver residue. Besides, weak coordination property did not 
25 
 
affect the ligand exchange process and helped maintaining the reactivity of this complex toward 
substrates in comparison with the classic ligand-Au/Ag salt system (Scheme 12B).
28
  
Scheme 12. Synthesis of [IPrAuNTf2] and its application in enyne cycloisomerization. 
 
These types of weakly coordinating moieties are described of the 'X-factor' in gold catalysis 
along with OH, MeCN, and triazoles, which will be discussed in greater detail later. 
 In TA-Au complex, triazole played the same role as ‘X-factor’. It provided us an opportunity 
to investigate not only the reactivity, but also the silver effect in gold(I) catalysis. A 
breakthrough result discovered in our group revealed a significant difference between Au-Ag and 
Au only activation. It has been reported before that adding the silver in some cases improved 
reactivity and reached better conversion and yield. To be worthy of attention, the silver promoted 
reactions showed the opposite result for the 'silver effect' comparing with Gagne's result (Figure 
9B).
29
 This comparison gained our interest and suggested that silver may function differently 
26 
 
than previously hypothesized. A TA-Au activated alkyne hydration initiated the investigation of 
difference between the pure Au and  Au/Ag mixture.  
Table 2. Silver effect in alkyne hydration.a 
 
Entry Catalyst Conditions Yield(%)
b
 ee(%) 
1 1% TA-Au 5h 87 90 
2 10% AgA
 c





 12h 0 - 
4 2% PPh3AuCl/AgOTf 12h 90 0 
5 2% PPh3AuCl/AgSbF6 8h 97 0 





 + AgSbF6 12h 91 - 
a General reaction conditions: 2.7 (1.0 equiv) and catalyst in 2.5 mL of dioxane/water (H2O, 










A direct comparison of different gold catalysts, with or without the presence of AgCl, was 
preformed (Table 2). As indicated in entry 2, under the optimal conditions reported by Sahoo 
(dioxane as solvent, 3 equiv. of H2O), none of the tested silver salts could catalyze the reaction, 




, which were prepared from 




 mixtures also could not promote this reaction (entry 3). 




 were used directly (without filtration of AgCl), 
the reaction worked as reported, though with complete stereochemical racemization (entries 4 
and 5). Careful degassing and N2 protection helped to avoid the racemization (entry 6). 
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 (the inactive complex obtained from filtration 
through celite) and AgSbF6 promoted this reaction effectively (entry 7), which suggested that the 
combination of gold and silver made the catalysis possible.  
The difference here is obvious. The filtering procedure differs between using a regular filter 
paper or a celite pipette. The celite pipette gravity filtration was proven to be an efficient method 
to reach a complete removal of silver salts, as indicated by X-ray photoelectron spectroscopy 
(XPS). 
 
Figure 10. XPS Spectra of (PPh3)AuCl/AgSbF6 Mixtures [(PPh3)AuCl:AgSbF6 = 1:1.5 after filtration 
through (A) Regular Filter Paper and (B) Celite 
 
As showed in Figure 10, Au signals were observed in both spectra which presents at the 
binding energy Au 4f7/2, 85.5 eV; Au 4f5/2, 89.2 eV. The silver signal appears in the spectrum 
following the filtration by filter paper at 7A: Ag 3d5/2, 368.7 eV; Ag 3d3/2, 374.7 eV. Whereas, 
the same signal was not found in the spectrum following celite gravity filtration. This result 
28 
 
unambiguously showed that the celite could serve to remove the silver effectively even when the 
silver is in relative excess (1.5/1.0 = Ag/Au).  
The LAuX (X indicates counter ion or X-factor in here) presents a linear spatial 
configuration, as a consequence, enables us to utilize 
31
P NMR spectroscopy to monitor the 
electronic nature of gold cations in solution. Different gold(I) species were tested and the 




P NMR Spectra of Different Au(I) Samples. General conditions :The chemical shifts were 
calibrated using 85% H3PO4 as an internal reference in a sealed capillary. The samples were prepared 
with 0.05 M gold in CDCl3. 
 




which was prepared by celite filtration, 
31
P resonance signal appeared at the most upfield with a chemical shift of 27.1 ppm (8D). 
However, the (PPh3)AuCl/AgOTf mixture without any filtration exhibited a signal at 28.1 ppm 




As a result, the development of methodologies that could provide easy access to stable and 
'silver free' gold(I) complexes are highly desirable.  
2.2 Efforts toward the synthesis of different 1,2,3-triazole gold(I) complexes 
 
Our group has focused on application of 1,2,3-triazole as a ligand system for years and 
several triazole based ligand-metal complexes were synthesized and characterized. The 




 and Au 
32
 proved that, 1,2,3-triazole is not, 
as previously assumed, an electron deficient heterocyclic structure lacking coordination ability. 
 
Figure 12. Different 1,2,3-triazole metal complexes obtained by Prof. Shi's group. 
 
In all cases, the triazole coordinated complexes showed improved stability toward moisture 
and air together with interesting reactivity. Among these results, the triazole-gold(I) (TA-Au) 
complexes gained the most attention from us through comparison with traditional gold catalysis. 
The new complexes synthesized displayed significantly improved reaction diversity and stability. 
Our group has discovered a series of methodologies of post-triazole functionalization (Figure 
30 
 
13). With these methods in hand, we could easily gain access to modified 1,2,3-triazoles and test 
their coordinating ability.  
 
Figure 13. Different post-triazole functionalization discovered by Prof. Shi's group. 
1,2,3-triazoles are structural isomers of the N-heterocyclic carbenes, with the ability to 
function as a good nitrogen σ-donor. Moreover, the electron deficient property of the triazole 




Figure 14. 1,2,3-triazole as structural isomer of NHC ligand: N σ-donor and better π-receptor 
 
Based on the prior publications by Nomiya and co-workers, triazole-gold(I) complexes have 
been achieved from a basic condition resulted in neutral complexes in 1998 (Shceme 13). 
Stoichiometric amounts of PPh3AuCl and respective triazole in the presence of the NaOH gave 
2.9 in moderate yield (51%). Isolation of the colorless crystal was performed by a vapor 
diffusion between benzene and hexane as internal and external solvents.
33
  
Scheme 13. Synthesis of triazole-gold(I) complexes reported by Nomiya. 
 
Follow the similar reaction condition, we prepared the two neutral 1,2,3-triazole gold(I) 
complexes with PPh3AuCl and benzotriazole/phenyltriazole as precursors in the presence of 
NaOH in MeOH.
34
 The product was isolated by recrystalization from CH2Cl2 and hexane, giving 
the pure product as white solids in quantitative yields. Cationic gold center netrual triazole 
complexes were also prepared by treating a mixture of benzotriazole/phenyltriazole and 
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PPh3AuCl with silver salt AgOTf. Removal of the AgCl precipitate through celite filtration gave 
a clear solution and upon condensation under vacuum, a white solid was obtained and 
recrystalized from CH2Cl2 and hexane to give colorless crystals in almost quantitative yield. 
Results are presented in Scheme 14. 
Scheme 14. Synthesis of triazole-gold(I) complexes reported by Prof. Shi. 
       
The complexes 2.11 and 2.12 in which the ligand is introduced as an anion are inert toward 
most of the tested substrates. The corresponding neutral triazole complex, 2.13a, could be 






Scheme 15. Silver free conversion from 2.11 to 2.13a. 
 
The arylation strategy works as an effective method for us to prepare functionalized triazoles 
with different electronic properties. To better investigate the modification ability of triazoles as 
ligands, a series of different N1-substituted benzotriazoles were prepared and treated with 
PPh3AuCl and AgOTf under the identical conditions as described in Scheme 14C. Orthogonal of 
primary ligand and triazoles was carried out to build a library of 1,2,3-triazole gold(I) complexes 
with different electronic properties. The result is summarized in Figure 15.  
The small library of triazole-gold(I) (TA-Au) complexes allowed us to investigate the 
reactivity of the catalysts with different electronic properties. A 
31
P NMR study was first 
conducted to evaluate the relative reactivity. The gold(I) chloride complex was considered 
unreactive, whereas, the cationic gold(I) with non-coordinating counter ion was considered as the 
most reactive species, the different substituted TA-Au complexes were assumed to show signals 
with chemical shifts between these two extreme cases. A series of TA-Au complexes was tested 




















P NMR spectra of different Au(I) samples. General conditions: the chemical shifts were calibrated 
using 85% H3PO4 as an internal reference in a sealed capillary. The samples were prepared with 0.05 M 
gold in CDCl3. 
 
As shown, the electronic properties could be easily tuned with different substituents on the 
triazole ring and a clear trend was observed. The substrate with the highest electron density 2.13f 
gave the most downfield chemical shift at 31.89 ppm, which is still very reactive when compare 
with the inert PPh3AuCl complex at 34.31 ppm. On the other end of the table, the very electron 
deficient substrate 2.13g presented the extreme case of less coordination and gave the signal at 
29.80 ppm, which is close to the 'pure' cationic gold(I) salt. All the other substrates lay between 
these two complexes providing an average distribution which means we might be able to tune the 
reactivity within a very small range and push the conversion with the most efficient model. To 
evaluate the electronic nature of these complexes, one model reaction was chosen to identify the 
difference through the kinetic investigation. The TA-Au catalyzed 3,3-rearrangement of 
propargyl ester to give an allene as the final product has been published before by our group.  
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The triazoles as second coordinating partner usually were known as secondary ligand (versus 
P ligand as the primary ligand) or 'X-factor' along with others such as MeCN, NTf2
-
, and 
pyridine. The 'X-factor' usually promoted the stability of the gold(I) cation toward moisture and 
air, meanwhile, adjusting the reactivity through an equilibrium ligand exchange process (Scheme 
16). 
Scheme 16. X-factor: an alternative strategy in tuning gold catalyst reactivity. 
 
Moreover, based on the recent observation of Au-Cl-Au or Au-Cl-Ag complexes, making the 
reaction mechanism more complicated, the catalytic cycle has been proposed by others (Figure 7) 
needs to be revised.  
 
2.3 Quantitative kinetic investigation of triazole–gold(I) complex catalyzed [3,3]-
rearrangement of propargyl ester 
 
The TA–Au complex could preferentially activate alkyne over allene in propargyl ester 3,3-
rearrangement, where indene was synthesized using 2 mol % IPrAuCl/AgBF4.
35
 However, in our 
case, no indene was detected after 12 h with the presence of 1 mol % TA-Au.
36
 We view this as a 
good opportunity for the mechanistic study. The simplified system may allow for the collection 
of quantitative kinetic information associated with TA-Au. In addition, it is also very important 
to understand the reason of the chemoselectivity offered by TA-Au, while other [L–Au]+ 
37 
 
complexes led to rapid racemization at the propargyl position and resulted in poor 
chemoselectivity (activation of both alkyne and allene). The quantitative kinetic investigation of 
TA-Au catalyzed propargyl ester 3,3-rearrangement using in situ IR spectroscopy from a ‘live’ 
catalytic reaction was performed.
37
 
Scheme 17. TA–Au as a chemoselective catalyst for alkyne activation. 
 
To acquire meaningful kinetic data for a catalytic reaction, the turnover-limiting step needs to 
be established. This is a challenging task for the LAuCl/AgX system, leading to the rapid 
catalyst decomposition over time. A unique advantage of the TA-Au catalyst is its improved 
stability, which allows relatively steady concentration of the catalyst for the kinetic study. Thus, 
we set out to evaluate the kinetic dependence of concentration of the substrate and TA-Au. The 






Scheme 18. Selection of TA-Au 2.13b as catalyst for alkyne activation. 
 
To avoid the potential influence of acid (formation of HOTf), the N-Me-benzotriazole 
(instead of N–H) coordinated TA–Au 2.13b was selected (Scheme 18). The dependence of the 
initial rates on the concentration of TA–Au catalyst 2.13b was studied with varying 
concentrations from 0.002–0.008 M. The initial rates in different runs were calculated based on 
the kinetic profiles monitored by in situ IR. A linear relationship is established as depicted in 
Figure 16. The reaction therefore shows first-order dependence on [2.13b], suggesting the 
involvement of 2.13b in the turnover-limiting step. 
 
Figure 16. Dependence of the initial rates on catalyst concentrations for rearrangement of 2.17. Reaction 






A subsequent experiment was performed to determine the kinetic order of [2.17]. Similarly, 
the initial rates were plotted against [2.17] varied from 0.10–0.20 M. Again, a first-order 
dependence was observed, as showed in Figure 17. Combining the two experiments, we were 




. According to the rate law, 
both the catalyst 2.13b and substrate 2.17 were involved, revealing the electronic activation of 
alkyne (i.e. ligand exchange) as the turnover-limiting step.  
 
Figure 17. Dependence of the initial rates on starting material concentrations for rearrangement of 2.17. 




With this kinetic data, a tentatively proposed mechanism of TA–Au catalyzed propargyl ester 
3,3-rearrangement is shown in Scheme 19. First, the TA–Au complex undergoes the turnover-
limiting ligand exchange with the substrate to form the cationic gold(I) alkyne π-complex. This 
complex then rapidly converts the propargyl ester to the corresponding allene. It is clearly seen 
that the ligand exchange step significantly slows the reaction rate compared to the use of free 
cationic gold(I) (Scheme 16), which is consistent with the fact that the same reaction catalyzed 
by IPrAu(L)
+





Scheme 19. Proposed mechanism for TA–Au catalyzed 3,3-rearrangement. 
 
Finally, we prepared various TA–Au catalysts with different substituted benzotriazoles in 
order to investigate the impact of the electronic nature of the TA–Au catalysts. The reaction 
kinetics are illustrated in Figure 18. Combining the 
31
P NMR peaks corresponding to TA–Au 
catalysts directly provides information regarding the electronic nature of the gold center.  
 
Figure 18. Kinetics profile using various TA–Au catalysts. Reaction conditions: 2.18 (0.10 M in DCE, 
1.2 mL), TA–Au (0.003 M in DCE), 26 °C. 
 
Clearly, the more cationic gold(I) species led to faster reaction rates. The slowest reaction 
was observed with the 4-methoxyphenyl substituted TA-Au catalyst. However, this reaction is 
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still faster than the reaction catalyzed by 2.13b, suggesting the inherent electron-withdrawing 
nature of the phenyl group attached to benzotriazole. The linear free energy relationship was 
established by plotting log(k/k0) vs. σpara, giving a ρ value of 0.74 (Figure 19). 
 
Figure 19. Hammett plot of various TA–Au catalysts. 
 
The positive ρ value suggested partial positive charge building up during the reaction, which 
is consistent with the associative ligand substitution being the turnover-limiting step. The more 
electron-deficient triazole undergoes ligand exchange more rapidly, which is due to the faster 
reaction rate. This result also highlights the tunability of the TA-Au catalyst. Based on the 
different cases, the more electron-deficient TA-Au will give a shorter reaction time, while the 
more electron-rich TA-Au has a longer catalyst lifetime. 
The chemoselectivity of the TA-Au catalysts (activation of alkyne over allene) can also be 
explained by this ligand–substrate exchange mechanism. The DFT calculation revealed that the 
HOMO of propargyl ester 2.17 is 20 kcal mol
−1
 higher than the HOMO of allene 2.19.
39
 Thus, 








In summary, a series of triazole-gold(I) complex (TA-Au) has been prepared and propargyl 
ester 3,3-rearrangement catalyzed by TA-Au complexes has been quantitatively investigated. 
Considering that few physical organic studies have been reported regarding gold catalyzed 
alkyne activation due to the poor catalyst stability and complex reaction nature, this work 
provided direct experimental evidence for understanding the elementary step in the TA-Au 
catalyzed alkyne activation. The discovery of associative ligand exchange between TA-Au and 





Qiaoyi Wang was the researcher who had first investigated the reaction kinetic profile. 
Yumeng Xi was responsible for the kinetic profile determination. Together Qiaoyi Wang, 
Yumeng Xi, Dr Jijin Su, and Dr Dawei Wang were responsible for the functional triazole 
complexes synthesis, NMR spectrum investigation and manuscript completion for successful 
submission to Chemical Communications. The DFT calculation was done by Prof. Minyong Li, 
at Department of Medicinal Chemistry, School of Pharmacy, Shandong University. The detailed 
X-ray crystallographic data analysis of compound 2.11， 2.12， 2.13a was done by Prof. Jeffrey 




Chapter Three: 1,2,3-triazoles work as X-factor to promote gold(I) 




As discussed in the previous section, we have built a small library of triazole-gold (TA-Au) 
complexes. This type of unique complex did not only as we expected, show pronounced stability 
compared to simple cationic gold(I), but also brought new reactivity. The fact that TA-Au only 
activates C-C triple bond over allene indeed offered an effective synthetic method of allene 
synthesis from more readily available commercial starting material - propargyl alcohol. 
 The first evidence for TA-Au complex activated C-C triple bond over allene was reported in 
the synthesis of E-α-haloenones as a kinetic favored product, whereas the corresponding 
thermodynamic favored Z-isomer has been separated as major product which has been published 
before (Scheme 20).
41
 According to the mechanistic investigation, the allene compound was 
widely adopted by researchers as the initiation intermediate after 3,3-rearrangement. However, 
the gold(I) species utilized as catalyst showed a lack of chemoselectivity and proceeded to 
activate allene sp carbon giving corresponding products. This investigation revealed that the E-
isomer observed in our publication was a direct substitution product in which the π-acid catalyst 





Scheme 20. α-haloenone through gold(I) activated propargyl ester gave Z/E isomers. 
 
Inspired by this discovery, a follow up discussion concerning the direct synthesis of allene 
through TA-Au catalyzed 3,3-rearrangement was reported later. In this research, effort was 
devoted to reach asymmetric synthesis of allenes through chirality transfer from an asymmetric 
reaction precursor.
42
 Both enantioenriched propargyl ester and propargyl vinyl ether were treated 
with TA-Au 2.13b, the allene products were isolated in high yields in both cases. Though, the 
allene ester product gave no ee value (Scheme 21A) likely due to the low energetic barrier of 
allene ester racemization process (∆G = 5.7 kcal/mol, t1/2 < 0.5 h),
43
 the allene aldehyde from 






Scheme 21. TA-Au catalyzed allene formation with chirality retention. 
 
Based on these breakthrough results, our group attempted to apply this unique transformation 
in more challenging chemical reactions. One of the examples is the schmittel cyclization 
promoted by TA-Au catalyst at room temperature.
44
  
Over the past several decades, thermal cycloaromatizations of enediyne (Bergman and 
Pascal)
45
 and enyne–allene (Myers-Saito and Schmittel)
46
 have attracted considerable attention 
due to their fundamentally intriguing mechanisms and the crucial biological applications.
47
 Prof. 
Bergman initiated the investigation of the cycloaromatization (C1-C6) of enediyne system in 
46 
 
1972. The following efforts have been devoted to this field demonstrated this type of 
transformation involved in a diradical intermediate.
48
 A possible competitive product of this 
reaction could be indene derivative from C1-C5 cycloaromatization. In 2008, Prof Pascal first 
discussed through computational and experimental data that, with diaryl substituent on the 




Scheme 22. Cyclization of enediyne derivative through diradical intermediate. 
 
An alternative process similar to this transformation has been discovered by Prof. Myers 
(named as Myers-Saito cyclization)
50
 for the first time in 1989 with enyne-allene as precursor 
followed the similar diradical intermediate to form cyclization (C2-C7) products. In contrast to 
the Bergman cyclization, this reaction exhibits a much lower activation barrier likely due to the 
higher reactivity of the allene moiety. Because of this higher reactivity, the reaction could 
perform at a lower temperature compared to the Bergman cyclization. Also, the alternative 
pathway (C2-C6) forms the indene derivative with the same enyne-allene precursor reported by 
Prof Schmittel
51
 and Prof. Wang
52
 independently in 1996 by the identical strategy of introducing 




Scheme 23. Cyclization of enyne-allene derivative through diradical intermediate. 
 
This type of reaction attracted attention due to the discovery of nature products containing 
endiyne moiety several years before.
53
 Calicheamicin exhibits high cytotoxic activity due to its 
ability to form the reactive diradical species even under physiological conditions.
54
 Here, the 
Bergman cyclization is activated by a triggering reaction. A distinguishing property of this 
diradical species is that it can effect a dual-strand cleavage of DNA. Neocarzinostatin
55
 is a 
bacterial antibiotic that also shows similar reactivity toward dual-strand DNA (Scheme 24). 






3.2 Result and discussion 
 
All this reactivity promotes this diradical precursor as a very attractive anticancer drug 
candidate. Developement of an appropriate molecule which could generate similar diradical 
intermediate under mild conditions became a hot topic in recent research. The results concerning 
diradical cyclization reactions are well documented.
56
 More specifically, the Bergman/Pascal 
cyclization with endiynes as precursors usually required high temperature to overcome the 
activation barrier. Whereas, enyne-allene precursor (Myers-Saito/Schmittel cyclization) exhibits 
a lower activation barrier, which made it a good candidate for further investigation.
57
 Usually 
reported temperature regarding enyne-allene system initiation, though much lower than endiyne 
activation temperature (around 200 
o
C), still need to be elevated (higher than human body 




 Photo-activation also promoted the enyne-allene 





Scheme 25. Myers-Saito reaction under thermal and photo activation conditions. 
 
To the best of our knowledge, no reported efficient conversion has been documented under 
mild conditions. Part of the reason is due to the lack of diversity of synthetic methodology 





 Our TA-Au catalyzed 3,3-rearrangement chemoselectively gave allene derivatives as 
a final product which provides a route to synthesize the enyne-allene system efficiently, which 
will finally allow an easy access to the diradical species (Scheme 26).  
Scheme 26. TA-Au catalyzed allene formation fused with enyne to access enyne-allene. 
 
The key aspects of this work are: (a) the use of TA-Au catalysts offered excellent 
chemoselectivity for selective formation of allene product 3.19 with no further activation; (b) the 
ability to form the cyclization with enyne-allene precursor effectively; (c) optimal conditions the 
enyne-allene activation towards the diradical cyclization. To test our hypothesis, two types of 
starting materials were synthesized and treated with TA-Au complex 2.13a, the reaction result 




Scheme 27. Propargyl ester/vinyl ether substrates treated with TA-Au. 
 
The propargyl ester 3.18a’ was treated with the TA-Au complex and no desired allene 
product was observed after 48 hours at room temperature. All the starting material was recovered 
with no conversion at all. To our delight, the propargyl vinyl ether was activated by the gold 
catalyst and gave the Schmittel cyclization product 3.20a and after subsequent reduction for easy 
isolation, alcohol 3.21a was separated with 35% isolated yields over two steps. This result was 
shocking, since the proposed allene product was not observed. Based on all the allene formation 
examples we have achieved before, we proposed that the enyne-allene derivative was 
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successfully formed by the TA-Au activation. After the formation of enyne-allene, the designed 
substrate exhibited high reactivity and performed the consequential Schmittel cyclization to form 
3.20a. 
Scheme 28. Proposed reaction process for the TA-Au catalyzed cyclization. 
 
Notably, the reaction with TA-Au catalyst was ‘clean’ and the only cyclization product 
observed was 3.21a. The major side competition process was the polymerization. No C2-C7 or 
other cyclization products were identified. The overall yield, though modest, was significantly 
higher than photoinitiation (Scheme 25B). The structure of 3.21a was confirmed by X-ray 
diffraction of the corresponding tosyl derivatives 3.24a as shown in Figure 20.  
The same type of reaction was reported by Prof. Wang and co-workers with very similar 
substrate and excellent yield (90%).
61
 Besides the efficient rearrangement forming enyne-allene 
intermediate, the steric hindrance group (such as tBu) was also proposed promoting the aromatic 
quenching process by pushing the aromatic substituent toward the sp
2
 radical (Scheme 29). 
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Combining both advances, the reaction was promoted to a level of efficiency that never had been 
achieved before. However, the in situ formation of enyne-allene required harsh conditions 
(treated with strong base and high temperature). 
Scheme 29. Schmittel cyclization reported by Prof. Wang with excellent efficiency. 
 
Overall, this result supported our hypothesis that (A) enyne-allene cyclization was 
energetically favored and could occur at room temperature, and (B) TA-Au catalyst could 
selectively activate the propargyl ether, generating the allene intermediates that allowed the 
subsequent aromatization. To the best of our knowledge, this is the first example of an enyne-




Figure 20. Perspective view of the structure of C32H26SO3 (compound 3.24a). The ball and stick drawing. 
CCDC number: 864331 
 
Screening of solvents revealed dichloromethane as the optimal solvent. Considering that 
polymerization was the major side reaction, different concentrations and reaction temperatures 
were evaluated (Table 4). The TA-Au catalyst lost reactivity at -10 
o
C. Raising the reaction 
temperature to 0 
o
C improved the overall reaction yield to 48% (Table 4, Entry 9). Whereas, the 
electron deficient substituent such as Br and NO2 provides better yield likely due to the stability 












 Solvent Conc. (M) T (
o
C) Conv (%) Yield(%)
c
 
1 CH2Cl2 0.075 -78 0 (4 h) N.D. 
2 CH2Cl2 0.075 -41 0 (4 h) N.D. 
3 CH2Cl2 0.075 -10 0 (4 h) N.D. 
4 CH2Cl2 0.075 0 >99 (6 h) 44 
5 CH2Cl2 0.075 rt >99 (15min) 35 
6 CH2Cl2 0.0025 0 >99 (48 h) 11 
7 CH2Cl2 0.005 0 >99 (48 h) 12 
8 CH2Cl2 0.01 0 >99 (48 h) 20 
9 CH2Cl2 0.1 0 >99 (48 h) 48 
10 CH2Cl2 0.1 0 >99 (48 h) 65 
11 MeCN 0.1 0 >99 (48 h) 47 
12 MeNO2 0.1 0 >99 (48 h) 26 
13 THF 0.1 0 >99 (48 h) 21 
14 acetone 0.1 0 >99 (48 h) 32 
15 MeOH 0.1 0 >99 (48 h) 15 
16 toluene 0.1 0 >99 (48 h) 41 
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17 DMF 0.1 0 >99 (48 h) 0 
18 DMSO 0.1 0 >99 (48 h) 0 
a
 General reaction condition: 3.18a (0.2 mmol), catalyst (3 mol %) in solvent, the reactions were 
monitored by TLC, 0 
o
C to rt. 
b
 entry 1-10 was tested with 3.18a, entry 11-19 was tested with 3.18c. 
c
 
Conversion and yields were determined by NMR with 1,3,5-trimethoxybenzene as internal standard. 
 
Some representative aromatic substituents at the allene termini were prepared to evaluate the 
reaction substrate scope. The results are summarized in Figure 21. 
 
Figure 21. Substrate scope of TA-Au catalyzed Schmittel cyclization. 
 
As illustrated in Figure 21, the C2-C6 cyclization could occur for both electron donating and 
electron withdrawing substituents on the aromatic rings. Electron withdrawing groups gave 
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significantly improved yields by reducing the undesired diradical polymerization.
62
 Conjugation 
did not show significant influence on the cyclization, which was consistent with the proposed 
mechanism that involved a highly reactive diradical intermediate. To further evaluate the 
reaction mechanism, propargyl vinyl ether with “reversed” substitution pattern (3.25a) and TMS-
substituted alkyne (3.25b) were prepared and reacted with TA-Au catalyst. As showed in 
Scheme 30A, propargyl ether 3.25a 3,3-rearrangement would produce the trisubstituted allene. 
Under the photocyclization condition shown in Scheme 25B, the diradical intermediates 
proceeded through two different reaction paths, which should lead to the formation of 3.26a and 
3.26a'. Interestingly, the TA-Au catalyzed conditions gave exclusively 3.26a as the cyclization 
product. This might be explained by the mild reaction conditions that favored the aromatic 
cyclization instead of the elimination (formation of 3.26a’), which highlighted the significantly 
improved selectivity of this method over thermal and photo conditions. Switching the alkyne 
termini substituents from Ph to TMS helped to successfully isolate the proposed allene 
intermediate 3.26b (Scheme 30B, decreasing cyclization reaction rates), which provided another 
piece of solid evidence for the proposed mechanism and the unique reactivity of TA-Au (activate 













In conclusion, reported herein is a new catalytic version of the Schmittel cyclization. The 
TA-Au catalyst offered impressive chemoselectivity, activating the specific alkynes only, which 
allowed the sequential cyclization to occur at much milder conditions. Both the allene 
intermediate and the final products were unambiguously confirmed. As a result, an effective new 
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strategy was uncovered under much milder conditions and enhanced substrate scope (substrates 
that could not be achieved with previously reported thermal or photo conditions). As 
consequence, this new method opens the possibility for mechanistic investigation and new 




Qiaoyi Wang was the researcher who had first investigated the reaction condition and 
mechanism investigation. Together, Qiaoyi Wang and Siddhita Aparaj were responsible for 
substrate scope, NMR spectrum, and manuscript completion for successful submission to 
Organic Letters. The detailed X-ray crystallographic data analysis of compound 3.24a was done 







Chapter Four: 1,2,3-triazoles work asX-factor to promote gold(I) 




'X-factor' assisted improvement of the gold(I) stability has been reported in several examples 
during the last decade. Along with the Tf2N
-
 as special counter ion (introduced in Chapter 2), 
MeCN exhibiting coordinating ability toward gold(I) complexes has been reported by Prof. 
Echavarren and co-workers as a neutral 'X-factor' in crystalline gold complex based on the 
Buchwald ligand in the year 2005 (Scheme 31).
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Scheme 31. MeCN as 'X-Factor' in gold(I) catalysis.  
 
1,2,3-triazole which plays the same role like acetonitrile in gold(I) complexes as a neutral 
coordinating moiety, has been reported by Prof. Shi's group in 2009.
64
 This strategy was applied 
in a hydroamination reaction of internal alkyne which usually requires harsh conditions such as 
an elevated reaction temperature. Both neutral and ionic triazole gold(I) complexes were tested 
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to promote the hydroamination along with other classic gold(I) complexes. While all tested 
complexes, with exception of TA-Au, showed low reactivity toward this specified reaction. The 
reaction profile is indicated in Figure 22.  
 
 
Figure 22. Reaction process profile: (a) 5% PPh3AuCl/AgOTf, rt; (b) 5% PPh3AuCl/AgOTf, 80 °C; (c) 5% 
PPh3AuNTf2, 80 °C; (d) 5% IPrAuNTf2, 80 °C; (e) 5% 2.13a + 5% benzotriazole, 80 °C; (f) 5% 2.13a, 
80 °C; (g) 1% 2.11, 2% H3PO4-12WO3, 80 °C; (h) 5% 2.11, 7% H3PO4-12WO3, 80 °C. 
The cationic gold(I) species PPh3AuCl/AgOTf, PPh3AuNTf2 and IPrAuNTf2 suffered from 
the catalyst decomposition and lost their reactivity (Figure 22, a-d). The ionic triazole gold(I) 
complex 2.11 originally showed no reactivity toward this reaction. The neutral triazole gold(I) 
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complex 2.13a exhibited significantly improved thermal stability at the raised temperature which 
was required in this reaction and reached an improved yield (Figure 22, f). When 5% of free 
benzotriazole was presented in the reaction port, a slower reaction rate was observed, which 
suggested a competitive ligand exchange process between triazole and the reaction substrate 4.4 
(Figure 22, e). The reaction was further promoted by the in situ generated activating gold(I) 
species with 2.11 by the addition of H3PO4-12WO3, reaching a yield of 91% with only 1% 
catalyst loading (Figure 22, g). 
This result was significantly encouraging in that the series of TA-Au complexes stabilized 
the gold(I) cation to a higher level which has not been previously reported. And with this 
innovative catalyst, our group were focused on exploring more challenging chemical 
transformations. The following case exhibited one example.  
The C=C moiety is one of the most common building block in organic molecules, and the 
aromatic groups accumulated by multiple C=C bonds play extremely important role in the 
science of chemistry. This important moiety could be substituted by two other atoms (N and B) 
to give the isoteric and isoelectronic structure of B-N. This isoelectronic relationship between 
CC and BN bond could be extended to all the other hybridisation stages. Though the 
isoelectronic bonds look similar, there are differences between these two structures. The most 
significant one is that, the BN unit is polarized whereas the CC unit is non-polar. Use C=C/B-N 
as an example, the polarity of BN unit was most contributed by the unequally distributed π 
electrons (or the p electrons on the N atom overlapping with the empty orbital on the B atom) 






Figure 23. Isoelectronic relationship between CC and BN, and molecular consequences of BN/CC 
isosterism. 
 
This interesting property initiated people's interest to substitute the CC unit with BN in the 
molecules with the expectation of different properties or reactivity that has been introduced by 
the BN polar bond. Efforts have been devoted to this area nearly a century ago (1926) since Prof. 
Stock and Pohland first reported the synthesis of borazine which was usually known as inorganic 
benzene.
66
 The word 'inorganic' precisely described the borazine property. The utility of this 
heterocyclic structure has been involved in serving as a precursor for BN based ceramic material 
synthesis
67
 and chemical hydrogen storage material
68
 more recently. The properties of both 
benzene and borazine have been thoroughly investigated since these two molecules have been 
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known for a relatively long time. However, another type of the isostructural compound 




Figure 24. Illustration of benzene, 1,2-dihydro-1,2-azaborine, and borazine. 
 
One of the major reasons for a lack of investigation of this 1,2-dihydro-1,2-azaborine is the 
lack of efficient synthetic method for the preparation. The benzene has been discovered by 
Faraday almost two hundred years ago,
70
 and one century later followed the borazine.
71
 However, 
the semi-substituted derivative 1,2-dihydro-1,2-azaborine has been very recently reported by 
Prof. Liu (in 2009).
72
 When comparing with the fast growing synthetic chemistry, this relatively 
late improvement explains the challenge in synthetic design and all other practical issue such as 
product stability.  
Similar substrate synthesis can be traced back to late 1950's by Prof. Dewar and co-workers. 










Scheme 32. Early stage synthetic route of 1,2-azaborines. 
 
Encouraged by these results, the same group has devoted their efforts to synthesize the parent 
1,2-dihydro-1,2-azaborinen through the hydroboration–oxidation strategy. Instead of the desired 
product, a trimerized product of BN-triphenylene was obtained. After the failed attempt to isolate 
the parent 1,2-dihydro-1,2-azaborinen,
75
 Dewar's group conclude that 'borazarene [1,2-dihydro-
1,2-azaborine] therefore seems to be a very reactive and chemically unstable system, prone to 
polymerization and other reactions…'  
Scheme 33. Attempt to synthesize parent 1,2-dihydro-1,2-azaborinen. 
 
Other pioneer work efforts toward the synthesis of 1,2-azaborine using secondary butenyl 





 The following dehydrogenation with Pd/Al2O3 provided the BH substrate 4.19 
which was later characterized by mass spectrometry.
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Scheme 34. BH 1,2-azaborine synthesis reported by Prof. Goubeau. 
 
These innovations along with other efforts such as desulfurization of BN-benzothiophenes 
with Raney nickel reported by Dewar and Gronowitz independently in 1960's hinted the potential 
arene mimics of the azaborine containing compounds.
78
 However, the early developments have 
been limited by the synthetic methodology and characterization technologies during that period. 
Modern synthetic methods and instrumentation have enabled a new generation of chemists to 
pick up where pioneering researchers left off, taking azaborine chemistry into uncharted and 
exciting territory. Prof. Ashe's group reached a breakthrough in the year 2000 based on the ring-
closing metathesis chemistry under mild conditions. Through this strategy, the 1,2-azaborine 
4.23 was achieved on a gram scale.
79
 In 2009, Prof. Liu's group reported a work following the 
same strategy by reducing the B-Cl bond with superhydride LiHBEt3, a similar BH substrate as 
reported before has been isolated.
80
 The TBS as a protecting group on N atom could be removed 
after a Cr π-complex formation (protection) with the treatment of HF-Py to give the parent 1,2-





Scheme 35. 1,2-azaborine synthesis based on ring-closing metathesis strategy. 
 
Similar strategy enabled Prof. Liu's group to synthesize a series of BN unit substituted 
structures with full characterization in the following years (Figure 25). The investigation of 




Figure 25. Structures reported by Liu's group with BN unit substituted CC unit. 
 
Among all the reported methods, one with high efficiency to access BN heterocyclic 
structure is the amine directed hydroboration of CC multiple bond reported by Goubeau and 
Dewar.
82
 Although Dewar failed on the primary amine substrate, this strategy still exhibits a very 
outstanding advantage: short synthetic route (only two steps). In contrast, Prof. Ashe and Liu's 
methods involved multi-step synthesis (which will decrease the overall product yield) and 
unstable intermediate such as aminoborane 4.21, required air and moisture free reaction 
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condition. The similar hydroboration strategy has been reported by Prof. Vedejs and co-workers 
in 2003 (Scheme 36).
83
 Their original focus is the amine directed hydroboration to reach a 
regioselective product 4.28 over the undesired product 4.30 from internal alkene precursors. The 
catalytic amount iodine introduced in the reaction mixture functionalized as a promoter which 
oxidized the less reactive amine-borane 4.26 to a more reactive intermediate with B-I bond 
presented. And the B-I bond in compound 4.27 was proposed to oxidize other unactivated 4.26 to 
achieve full conversion. It is worth noting that the BN including intermediate 4.27 was 
successfully isolated in two cases among the substrates with moderate yields (<50% for both).  
Scheme 36. Regioselective hydroboration reported by Vedejs. 
 
The moderate yield observed for this result compared to the excellent yields of the final 
products 4.28, suggested that, the BN cyclic structure is less stable. This is probably due to the 
less stable sp
3
 hybridized C-B bond. If the hybridization could be switched to sp
2
 (vinyl borane 





Therefore, our group initiated the investigation of alkyne hydroboration reaction to form the BN 
heterocyclic structure more effectively.  
 
4.2 Result and discussion 
 
Scheme 37. Intramolecular hydroboration of alkyne: efficient but no precedence. 
 
As indicated in Scheme 37, the amine directed alkyne hydroboration could provide an 
efficient approach to cyclic amine-borane compounds through either endo or exo transition state. 
The reaction has not previously been reported so far, likely due to the less reactive CC triple 
bond and the reduced reactivity of amine-borane. The iodine activation strategy adopted by 
Vedejs successfully solved the amine-borane reactivity issue.
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 Therefore, the same strategy has 
been applied to the propargyl amine-borane complex to evaluate the performance of this reaction 
pattern on alkyne. 




The catalytic amount of iodine could not promote the substrate 4.34 under identical reaction 
conditions as reported in alkene hydroboration by Vedejs (Scheme 38A). Meanwhile, the excess 
amount of iodine caused a serious decomposition of 4.34 and gave a complex mixture with 39% 
propargyl amine recovered. Although I
-
 served as a good leaving group, the very reluctant CC 
triple bond still had not be activated yet. Two alternative strategies intuitively came out are: 1) 
transition metal catalyzed hydroboration through more active M-H intermediate; 2) π-acid 
activation of CC triple bond induced hydroboration. These two activaton models are indicated in 
Scheme 39. 






These two strategies presumably will help to overcome the major challenges associated with 
this transformation: 1) the low reactivity of alkyne; 2) the possibility of double addition rather 
than desired mono-hydroboration. 
Although transition metal catalyzed hydroboration suffered from catalyst decomposition, 
successful examples have been reported.
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 To avoid the undesired catalyst decomposition 
(caused by boron hydride reduction), almost all of the reported cases used metal cations or nano-
particles that were able to form a metal hydride (M-H) bond. Meanwhile, a close inspection of 
the mechanism revealed that the very available M-H promoted hydride addition is not suitable 
for the N-B bond cyclization product formation (through M-B transmetallation, Scheme 
39A).The cis-addition of alkyne led to the formation of trans-isomer based on the structure 
confirmation and resulted to the boron atom and metal locating on different sides of the C=C. 
The proposed transmetallation process will then be blocked and could not form the desired 
product efficiently. Thus, transition metal catalyzed alkyne hydroboration for the synthesis of 
cyclic amine borane has not been achieved in the past. 
Metal hydride strategy has been ruled out, the only hypothesis left is the Lewis acid activated 
alkyne hydroboration. Based on this activation mode, we hypothesized that a cyclic amine 
borane could be synthesized through the intramolecular alkyne hydroboration as showed in 
Scheme 39B. An appropriate acidic transition metal catalyst that tolerates boron hydride 
substrates and an amine borane precursor could be identified. Two practical concerns are: 1) the 
stability of active metal catalysts to survive the reductive conditions and 2) the feasibility of the 
proposed M-B transmetallation. The efficient π-acid catalysts for CC triple bond activation has 
been identified to be gold and platinum so far.  
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While interesting reactivity has been observed with the triazole-gold (TA-Au) complexes in 
our group, the main advantage of this catalyst is the significantly improved stability.
87
 Thus, we 
postulated that the TA-Au catalysts would provide the required π-acid reactivity toward alkyne 
activation while maintaining stability toward the borane, and thus affording a new efficient 
synthesis of the challenging cyclic amine borane under mild conditions. 







), were tested to promote hydroboration of amine borane 4.34 
(which was generated in situ by mixing propargyl amine in borane-THF solution). Unfortunately, 
significant gold decomposition, as evidenced by the formation of gold nanoparticles or a gold 
mirror occurred, even with the TA-Au catalysts (Table 5, entry 7-12). Corma and coworkers 
have recently reported the highly efficient alkyne hydration with small gold clusters.
88
 Their 
work suggested the in situ formation of Au(0) cluster as the active catalysts which successfully 
promoted the hydroboration of both internal and terminal alkynes. Unfortunately, no reaction 
other than starting material decomposition occurred after this reduction process by amine borane 
4.34. This result is probably due to the formation of a catalytically inactive Au(0) species. 
Table 5. Screening of the gold catalyst for amine directed alkyne hydroboration. 
 
Entry Au catalyst Time Conv. (%) Yield (%) 
1 PPh3AuCl/AgOTf 1 hr or 24 hr <5 n.d. 
2 IPrAuCl/AgOTf 1 hr or 24 hr <5 n.d. 
3 XPhosAuCl/AgOTf 1 hr or 24 hr <5 n.d. 
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 1 hr or 24 hr <5 n.d. 
General reaction condition: 4.34 (0.2 mmol), catalyst (5 mol %) in solvent (1 ml), the reactions were 
monitored by TLC, 0 
o
C to RT. Conversion and yields were determined by NMR with 1,3,5-
trimethoxybenzene as the internal standard. 
 
This problem may be a consequence of boron hydride reduction. To overcome this problem, 
we developed the “less reactive” amine borane that would slow down the decomposition of our 
gold catalysts. The pinacolborane and catecholborane were treated with propargyl amine to form 
the desired product with B-O bond substituent to lower the B-H reductivity. However, these two 
boron sources did not form the amine borane complexes very efficiently.  




After extensive screening of various substrates, the cyano-substituted amine borane 4.38 was 
prepared by the general synthetic route shown in Scheme 41. 
Scheme 41. Conditions for synthesis of amine boranecarbonitrile 4.39. 
 
Propargyl amine hydrochloride salt 4.38, was treated with NaBH3CN and MgSO4 in THF. 
The reaction mixture was maintained at reflux and provide the desired product 4.39 with high 
efficiency (generally yield > 85%), with both primary and secondary amine substrates being 
tolerated. A Series of 4.39 with different substrates was prepared and summarized in Figure 26. 
 
Figure 26. Substrate scope of boranecarbonitrile 4.39. 
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An X-ray structure analysis of 4.39a confirmed the proposed structure.  
           
Figure 27. Perspective view of the structure of C10H11BN2 (4.39a). The ball and stick drawing. CCDC 
number: 954118 
This method tolerated various substitute groups at the alkyne terminus. Both the primary and 
aliphatic substituted secondary propargyl amine worked well for the B-N complex formation. 
The aromatic substituted propargyl amine (R2 = Ar) did not give the corresponding complex 4.39 
under the optimal conditions, which is likely a consequence of the decreased basicity of the 
nitrogen. Nevertheless, this method allowed the general access to the cyano-stabilized amine 
borane, containing the less reactive borohydride (B-H). 
With this new amine borane 4.39 in hand, we investigated its reactivity toward gold catalysts.  
Notably, compared to the terminal alkyne, the internal alkyne is usually much less reactive 
toward π-acid catalysts. Therefore, to better validate the feasibility of this gold catalyzed 
intramolecular hydroboration, complex 4.39b (containing internal alkyne) was selected for our 
initial screening.  The results are summarized in Table 6. 




Entry Catalyst Solvent t [h] T [ 
o
C] Conv. Yield 
1 PPh3AuCl CH2Cl2 rt 72 hr <5 % n.d. 
2 PPh3AuCl/AgOTf CH2Cl2 rt 30 min or 72 hr 19 % 17 % 
3 IPrAuCl/AgOTf CH2Cl2 rt 30 min or 72 hr 15 % 11 % 
4 XPhosAuCl/AgOTf CH2Cl2 rt 30 min or 72 hr <5 % n.d. 























CH2Cl2 rt 30 min or 72 hr 16 % 2 % 
10 PPh3AuCl DCE 80 72 hr <5 % n.d. 
11 XPhosAuCl/AgOTf DCE 80 30 min or 72 hr 10 % 5 % 













































 MeCN 80 72 hr 88 % 65 % 
General reaction conditions: 4.39b (39 mg, 0.2 mmol 1.0 eq.), solvent (5 mL) and [Au] catalyst (0.01 
mmol, 5 mol %).was successively added into 20 mL reaction vial and stirred at coorespounding 
temprature. rt = room temperature, n.d. = not determined, TA = 1H-benzo[d][1,2,3]triazole. Conversion 
and yields were determined by NMR with p-xylene as internal standard. 
 
Unlike amine borane 4.34 which caused rapid gold decomposition, the cyano-substituted 
amine borane 4.39b gave the desired cyclic amine borane 4.40b using the PPh3AuCl/AgOTf 
catalyst, though with very low yield (17%, entry 2). The structure of 4.40b was confirmed by X-
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ray crystallography (Figure 28). Notably, the reaction gave 3:1 (cis:trans) isomer mixture in 
solution. However, upon crystallization, all of the trans-isomer converted to cis-isomer. This 
process was confirmed by NMR: re-dissolving the cis-isomer indicated a slow equilibrium (up to 
3 hours) to 3:1 cis-trans mixture, and slow evaporation the solvent gave the pure cis-isomer again. 
Overall, the success in obtaining the cyclic amine borane 4.40b greatly supported our hypothesis 
that the π-acidic gold catalyzed alkyne activation is a feasible approach for the preparation of 
cyclic amine borane. To improve the reaction performance, we screened other gold catalysts. As 
showed in entries 1-5, although the cyano-modified amine borane 4.39b was a weaker reductant, 
the reaction still suffered from gold decomposition. Interestingly, the TA-Au catalysts (entry 6), 
though giving no reaction, indicated better resistance toward 4.39b, according to the decreased 
rate of gold mirror formation. To verify this result, we monitored the catalyst decomposition 
(upon treatment with cyano-substituted amine borane 4.39b) using 
31
P NMR (Figure 29). 
 
Figure 28. Perspective view of the structure of C12H15BN2 (compound 4.40b). The ball and stick drawing. 
CCDC number: 954119 
 
As shown, treating [L-Au]+ with 4.39b caused immediate decomposition, even with XPhos 
as the primary ligand. Interestingly, with the 1,2,3-triazole modified gold complexes, much 
slower decomposition was observed. The bulky XPhos ligand further improved the gold cation 
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stability, giving little decomposition even after 20 hours at room temperature. With this 
improved catalyst stability, we further evaluated the reaction conditions at elevated temperature. 
To our great delight, with the XPhos-based TA-Au catalyst at 80 
o
C, 4.39b was consumed and 
4.40b was isolated in excellent yield (93%, Table 5, entry 9).  Solvent screening revealed DCE 







 were also evaluated. Triazole-gold complex gave the best result 
due to the superior stability under the applied reductive conditions (see detailed screening 
conditions and 
31
P NMR spectra in supporting information). 
 
Figure 29. Monitoring the gold decomposition by 
31
P NMR. General conditions: 
31
P NMR was collected 
at room temperature in CDCl3 with a sealed capillary tube containing H3PO4/D2O (1.0 M) solution as 
external standard for integration (100), and chemical shift (δ = 0.00 ppm). 
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With this optimized conditions in hand, we explored the reaction substrate scope.  The results 
are summarized in Figure 30. As shown, this method tolerated large substrate scope. First, both 
terminal and internal alkynes were adapted for this transformation. The more reactive terminal 
alkynes gave excellent yields (4.40h and 4.40i).  Most of the tested internal alkynes also worked 
well under this condition. The alkyne terminal (R
1
) can be alkyl, aryl, cyclopropyl and even 
alkenyl (from enyne).  The aliphatic internal alkynes were less reactive, giving slightly lower 
yields (4.40e and 4.40f) compared to the aromatic internal alkynes. Electron donating group 
substituted alkyne (4.39j to 4.40j) reacted slowly under the applied conditions (even with an 
extended reaction period, 4 days). The reaction was quenched upon the observed decomposition 
of starting material 4.39j. The overall yield was moderate when compared with the electron 
deficient substrate 4.39k. No ring-opening product was observed in the cyclopropane modified 
alkyne (4.40g), excluding a single electron mechanism in this transformation. Both primary and 
secondary propargyl amines were tolerated with the reaction conditions, giving cyclic amine 
borane product as a mixture of cis-trans isomers with different ratios (4.40b, 4.40f and 4.40i). 
The overall reactivity of these two types of amines was comparable. Substitution on the 
propargyl R
3
 position indicated little influence on the reactivity, giving 4.40c in excellent yield.  
Overall, the good substrate tolerability at alkyne terminal (R
1





) positions highlighted the great potential of this method for the preparation of 






Figure 30. Reaction substrate scope. All conversion, yield and dr was determined after 72 hr (96 hr for 
4.40j) by NMR with p-xylene as internal standard. 
 
To emphasize the practical utility of this method, a 5 mmol scale reaction of 4.39a was 
performed under the identical conditions and 4.40a was isolated as a white solid in 85% yield. 
The cyano group on boron was originally introduced to overcome the undesired gold catalyst 
decomposition. Thus, to further extend this methodology as a general protocol for potential 
azaborine synthesis, we investigated the post-cyclization derivatization with the expectation to 
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introduce diverse functional groups on the boron position. Two representative transformations on 
the B position are summarized in Scheme 42. 
Scheme 42. Introducing functional groups at boron position. 
 
First, treating the cyclic amine borane 4.40a/4.40b with LiAlH4 gave the corresponding 
reduction product 4.41a/4.42b in good to excellent yields (Scheme 42A).
90
 Notably, the non-
substituted amine borane 4.41a was not stable toward air. Thus, although excellent NMR yield 
(91%) was observed, only 73% product was isolated. This was probably due to the loss of H2 gas 
and sequential decomposition. Nevertheless, considering the fact that the BH3 based amine 
borane 4.34 caused rapid gold decomposition and was not suitable for this transformation at all, 
this cyano borane modification provided an alternative solution to extend the reaction scope. 
Moreover, reaction of 4.40a with 3 equiv. PhMgBr gave the corresponding phenyl substituted 
cyclic amine borane 4.42 with the structure confirmed by X-ray crystallography (Figure 31). 
Combining these two strategies in Scheme 42, functionalization of the boron position was 
readily achievable, and highlighted the large scope of cyclic amine borane synthesis that can be 




Figure 31. Perspective view of the structure of C16H15BN2 (compound 4.42). The ball and stick drawing. 




Overall, we report herein a novel strategy for the highly efficient preparation of cyclic amine 
boranes.  With the newly developed cyano-modified amine borane and stable XPhos-based TA-
Au catalyst, the inherently challenging alkyne hydroboration was achieved successfully. The 
overall transformation operated under “open-flask” conditions. The excellent substrate 
tolerability and readily available derivatization methods warrant this transformation as an new 
efficient approach for cyclic amine borane synthesis in general. Preparation of other BN/CC 
isosteric derivatives (such as benzene and indole) and applications of the resulting compounds in 
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Chapter One: Iron catalyzed C-O bond activation for the synthesis of 
propargyl-1,2,3-triazoles and 1,1-bis-triazoles 
 
I. General Methods and materials 
 
All of the reactions dealing with air and/or moisture-sensitive reactions were carried out under an 
atmosphere of nitrogen using oven/flame-dried glassware and standard syringe/septa techniques. 
Unless otherwise noted, all commercial reagents and solvents were obtained from the 
commercial provider and used without further purification. 
1
H NMR and 
13
C NMR spectra were 
recorded on Varian 600 MHz spectrometers. Chemical shifts were reported relative to internal 
tetramethylsilane ( 0.00 ppm) or CDCl3 ( 7.26 ppm) for 
1
H and CDCl3 ( 77.0 ppm) for 
13
C. 
Flash column chromatography was performed on 230-430 mesh silica gel. Analytical thin layer 
chromatography was performed with precoated glass baked plates (250μ) and visualized by 
fluorescence and by charring after treatment with potassium permanganate stain. Melting points 
were measured on a Mel-Temp 1001D apparatus and uncorrected. HRMS were recorded on 
LTQ-FTUHRA spectrometer. 
 
Substrates 1.2b, 1.4 were synthesized according to the literatures as below: 
1. Yu, M.; Zhang, G.; Zhang, L. Org. Lett. 2007, 9, 2147-2150. 
2. Marion, N.; Carlqvist, P.; Gealageas, R.; Fremont, P.; Maseras, F.; Nolan, S. P. Chem. 
Eur. J. 2007, 13, 6437-6451. 
3. Wang, D.; Ye, X.; Shi, X. Org. Lett. 2010, 12, 2088-2091. 
 




To a solution of hex-1-yne (39 mmol) in anhydrous THF (50 mL) at –78 °C under N2 
atmosphere was added n-BuLi (1.6 M solution in hexanes, 20.6 mL, 33 mmol). The reaction was 
stirred at this temperature for 20 min then at room temperature for 1h. After cooling to at –78 °C, 
benzaldehyde (30 mmol) was added to the mixture and was allowed to warm to room 
temperature gradually and stirred for an additional hour. After addition of acetate anhydrous (60 
mmol) at 0 °C, the reaction mixture was warmed to room temperature and stirred for 2h before 
quenched with aqueous NH4Cl. The mixture was extracted with EtOAc (3 x 20 mL), and the 
combined organic phases were washed with water and brine, dried with anhydrous MgSO4, and 
filtered. The filtrate was concentrated under reduced pressure and the residue was purified by 
flash chromatography on silica gel (hexanes/ethyl acetate, V/V, 20:1) to produce the desired 
acetate as yellow oil in quantitative yield. 
 
Representative procedure for the preparation of propargylic alcohol 1.4 
 
To a solution of alkyne (39 mmol) in anhydrous THF (50 mL) at –78 °C under N2 atmosphere 
was added n-BuLi (1.6 M solution in hexanes, 20.6 mL, 33 mmol). The reaction was stirred at 
this temperature for 20 min then at room temperature for 1h. After cooling to at –78 °C, aldehyde 
(30 mmol) was added to the mixture and was allowed to warm to room temperature gradually 
and stirred for an additional hour before quenched with aqueous NH4Cl. The mixture was 
extracted with EtOAc (3 x 20 mL), and the combined organic phases were washed with water 
and brine, dried with anhydrous MgSO4, and filtered. The filtrate was concentrated under 
reduced pressure and the residue was purified by flash chromatography on silica gel 
(hexanes/ethyl acetate, V/V, 15:1) to produce the desired alcohol as yellow oil in quantitative 
yield. 
 
Representative procedure for propargylation of 1.4 with triazoles 
 
A solution of propargylic alcohol (1 mmol) and triazole (1.2 mmol) with catalyst iron(III) 
chloride (0.1 mmol) in  acetonitrile (10 ml) was stirred at 90 degree in the presence of water 
100 
 
condensor for 5h.  The reaction mixture was quenched with 10 ml distilled water and then 
extracted with EtOAc (3 x 10 mL). The combined organic phases were washed with water and 
brine, dried with anhydrous MgSO4, and filtered. The filtrate was concentrated under reduced 
pressure and the residue was purified by flash chromatography on silica gel (hexanes/ethyl 
acetate, V/V, 15:1) to produce the desired product as yellow oil except for 1.3f. 
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II. Compounds Characterization 
 
 
1-(1-phenylhept-2-ynyl)-1H-benzo[d][1,2,3]triazole (1.3a (N1)): 
1
H-NMR (600 MHz, CDCl3) 
δ 8.04 (d, J = 8.4 Hz, 1H), 7.54-7.51 (m, 3H), 7.37-7.29 (m, 5H), 7.14 (s, 1H), 2.34 (dt, J = 7.2 
Hz, 2.4 Hz, 2H), 1.56 (quintet, J = 7.2 Hz, 2H), 1.42 (hextet, J = 7.2 Hz, 2H), 0.90 (t, J = 7.2 Hz, 
3H); 
13
C-NMR (150 MHz, CDCl3) δ 146.7, 1 5.9, 1 1. , 128.7, 128.6, 127.1, 12 .9, 120.0, 
111.1, 90.3, 73.6, 55.5, 30.4, 21.9, 18.4, 13.4; HRMS Calculated for C19H20N3 [M+H]
+
: 
290.16572, Found: 290.16517. 
 
 
4-phenyl-1-(1-phenylhept-2-ynyl)-1H-1,2,3-triazole (1.3b (N1)): 
1
H-NMR (600 MHz, CDCl3) 
δ 7.89 (s, 1H), 7.82 (d, J = 7.8 Hz, 2H), 7.52 (d, J = 7.2 Hz, 2H), 7.41-7.30 (m, 6H), 6.73 (s, 1H), 
2.37 (dt, J = 7.2 Hz, 1.8 Hz. 2H), 1.60 (quintet, J = 7.2 Hz, 2H), 1.47 (hextet, J = 7.2 Hz, 2H), 
0.95 (t, J = 7.2 Hz, 3H); 
13
C-NMR (150 MHz, CDCl3) δ 148.0, 1 6.7, 1 0.5, 129.0, 128.8, 128.7, 
128.1, 127.1, 125.7, 118.0, 90.1, 74.4, 56.3, 30.4, 22.0, 18.5, 13.5; HRMS Calculated for 
C21H22N3 [M+H]
+





4-phenyl-2-(1-phenylhept-2-ynyl)-2H-1,2,3-triazole (1.3b (N2)): 
1
H-NMR (600 MHz, CDCl3) 
δ 7.89 (s, 1H), 7.81 (d, J = 7.2 Hz, 2H), 7.59 (d, J = 7.2 Hz, 2H), 7.42 (t, J = 7.2 Hz, 2H), 7.39-
7.32 (m, 5H), 2.37 (dt, J = 7.2 Hz, 1.8 Hz, 2H), 1.59 (quintet, J = 7.2 Hz, 2H), 1.47 (hextet, J = 
7.2 Hz, 2H), 0.94 (t, J = 7.2 Hz, 3H); 
13
C-NMR (150 MHz, CDCl3) δ 147.9, 1 7.0, 1 1.7, 1 0. , 
128.7, 128.6, 128.5, 128.4, 127.4, 126.0, 89.3, 74.7, 60.8, 30.4, 21.9, 18.6, 13.5; HRMS 
Calculated for C21H22N3 [M+H]
+
: 316.18137, Found: 316.18082. 
 
 
phenyl(5-phenyl-1-(1-phenylhept-2-ynyl)-1H-1,2,3-triazol-4-yl)methanone (1.3c (N1)): 
1
H-
NMR (600 MHz, CDCl3) δ 8.26 (d, J = 7.2 Hz, 2H), 7.56 (d, J = 7.2 Hz, 1H), 7.47 (t, J = 7.2 Hz, 
2H), 7.38-7.29 (m, 4H), 7.25-7.23 (m, 4H), 7.05 (dd, J = 7.2 Hz, 2.4 Hz, 2H), 6.27 (t, J = 3.6 Hz, 
1H),  2.71 (dt, J = 7.2 Hz, 1.8 Hz, 2H), 1.54 (quintet, J = 7.2 Hz, 2H), 1.28 (hextet, J = 7.2 Hz, 
2H), 0.89 (t, J = 7.2 Hz, 3H); 
13
C-NMR (150 MHz, CDCl3) δ 186.4, 141.9, 141.5,1 7.1, 1  .0, 
131.9, 130.7, 129.8, 129.6, 128.7, 128.5, 128.4, 128.2, 127.8, 127.4, 126.8, 111.8, 103.4, 32.3, 
28.7, 22.0, 13.7; HRMS Calculated for C28H26N3O [M+H]
+





phenyl(5-phenyl-2-(1-phenylhept-2-ynyl)-2H-1,2,3-triazol-4-yl)methanone (1.3c (N2)): 
1
H-
NMR (600 MHz, CDCl3) δ 8.08 (d, J = 8.4 Hz, 2H), 7.83 (dd, J = 7.2 Hz, 2.4 Hz, 2H), 7.63 (d, J 
= 7.2 Hz, 2H), 7.59 (t, J = 7.8 Hz, 1H), 7.46 (t, J = 7.8 Hz, 2H), 7.41-7.37 (m, 6H), 6.69 (t, J = 
2.4 Hz, 1H), 2.37 (dt, J = 7.2 Hz, 2.4 Hz, 2H), 1.60 (quintet, J = 7.2 Hz, 2H), 1.48 (hextet, J = 
7.8 Hz, 2H), 0.94 (t, J = 7.2 Hz, 3H); 
13
C-NMR (150 MHz, CDCl3) δ 187.7, 149.9, 142.1, 1 7.2, 
136.4, 133.2, 130.6, 129.7, 129.0, 128.9, 128.8, 128.7, 128.2, 128.1, 127.6, 90.0, 74.3, 61.5, 30.4, 
21.9, 18.6, 13.5; HRMS Calculated for C28H26N3O [M+H]
+
: 420.20759, Found: 420.20704. 
 
 
1-(3-cyclopropyl-1-phenylprop-2-ynyl)-1H-benzo[d][1,2,3]triazole (1.3d (N1)): 
1
H-NMR 
(600 MHz, CDCl3) δ 8.05 (d, J = 8.4 Hz, 1H), 7.52 (d, J = 7.8 Hz, 1H), 7.49 (d J = 7.2 Hz, 2H), 
7.38-7.29 (m, 5H), 7.10 (s, 1H), 1.40-1.37 (m, 1H), 0.86-0.83 (m, 2H), 0.78-0.75 (m, 2H); 
13
C-
NMR (150 MHz, CDCl3) δ 14 .4, 1 6.0, 1 4.6, 1 1.8, 128.8, 128.7, 127.2, 127.0, 12 .9, 120.0, 
111.1, 93.2, 68.7, 55.5, 8.4; HRMS Calculated for C18H16N3 [M+H]
+




1-(1,3-diphenylprop-2-ynyl)-1H-benzo[d][1,2,3]triazole (1.3e (N1)): 
1
H-NMR (600 MHz, 
CDCl3) δ 8.08 (d, J = 7.2 Hz, 1H), 7.60-7.64 (m, 3H), 7.52 (d, J = 7.8 Hz, 2H), 7.40-7.33 (m, 
9H); 
13
C-NMR (150 MHz, CDCl3) δ 146.8, 1 5.4, 1 1.8, 1 1.4, 129.2, 128.9, 128.8, 128.4, 
127.4, 127.0, 124.0, 121.5, 120.1, 111.0, 89.1, 82.4, 55.7; HRMS Calculated for C21H16N3 
[M+H]
+





1-(1,3-diphenylprop-2-ynyl)-4-phenyl-1H-1,2,3-triazole (1.3f (N1)): 
1
H-NMR (600 MHz, 
CDCl3) δ 7.96 (s, 1H), 7.8  (d, J = 8.4 Hz, 2H), 7.61 (d, J = 7.2 Hz, 2H), 7.55 (d, J = 7.2 Hz, 
2H), 7.44-7.37 (m, 8H), 7.33-7.31 (m, 1H), 6.99 (s, 1H); 
13
C-NMR (150 MHz, CDCl3) δ 148. , 
136.2, 131.9, 130.5, 129.3, 129.2, 129.1, 128.8, 128.5, 128.2, 127.2, 125.8, 121.4, 118.1, 88.8, 
83.1, 56.7; HRMS Calculated for C23H18N3 [M+H]
+
: 336.15007, Found: 336.14992. 
 
 
2-(1,3-diphenylprop-2-ynyl)-4-phenyl-2H-1,2,3-triazole (1.3f (N2)): 
1
H-NMR (600 MHz, 
CDCl3) δ 7.95 (s, 1H), 7.86 (d, J = 7.2 Hz, 2H), 7.72 (d, J = 7.2 Hz, 2H), 7.59 (dd, J = 7.2 Hz, 
2.4 Hz, 2H), 7.45 (q, J = 7.8 Hz, 4H), 7.40-7.35 (m, 5H), 6.94 (s, 1H); 
13
C-NMR (150 MHz, 
CDCl3) δ 148.2, 1 6.4, 1 1.9, 1 1.8, 1 0.2, 128.9, 128.8, 128.7, 128.5, 128.2, 127.5, 126.0, 
122.0, 88.0, 83.7, 61.0; HRMS Calculated for C23H18N3 [M+H]
+
: 336.15007, Found: 336.14992. 
 
 
(2-(1,3-diphenylprop-2-ynyl)-5-phenyl-2H-1,2,3-triazol-4-yl)(phenyl)methanone (1.3g (N2)): 
1
H-NMR (600 MHz, CDCl3) δ 8.10 (d, J = 8.4 Hz, 2H), 7.86 (d, J = 7.8 Hz, 2H), 7.72 (d, J = 7.2 
Hz, 2H), 7.60 (t, J = 7.8 Hz, 1H), 7.56 (d, J = 7.8 Hz, 2H), 7.47-7.34 (m, 11H), 6.94 (s, 1H); 
13
C-NMR (150 MHz, CDCl3) δ 187.6, 150.1, 142. , 1 7.2, 1 5.8, 1  . , 1 1.9, 1 0.6, 129.6, 
105 
 
129.2, 129.1, 129.0, 128.9, 128.8, 128.4, 128.3, 128.2, 127.8, 121.8, 88.7, 83.1, 61.8; HRMS 
Calculated for C30H22N3O [M+H]
+
: 440.17629, Found: 440.17679. 
 
 
1-(1-(naphthalen-1-yl)hept-2-ynyl)-1H-benzo[d][1,2,3]triazole (1.3h (N1)): 
1
H-NMR (600 
MHz, CDCl3) δ 8.25 (d, J = 9.0 Hz, 1H), 8.19 (d, J = 7.2 Hz, 1H), 7.99 (d, J = 8.4 Hz, 1H), 7.87 
(d, J = 8.4 Hz, 1H), 7.82 (d, J = 9.0 Hz, 2H), 7.55 (t, J = 7.2 Hz, 1H), 7.48-7.41 (m, 3H), 7.30-
7.23 (m, 2H), 2.32 (dt, J = 7.2 Hz, 2.4 Hz, 2H), 1.54 (quintet, J = 7.2 Hz, 2H), 1.39 (hextet, J = 
7.2 Hz, 2H), 0.88 (t, J = 7.2 Hz, 3H); 
13
C-NMR (150 MHz, CDCl3) δ 146.6, 1 4.0, 1 1.7, 1 0.6, 
130.5, 130.3, 128.8, 127.1, 127.0, 126.5, 126.1, 124.8, 123.7, 122.9, 120.0, 111.1, 90.5, 74.3, 
53.7, 30.4, 21.9, 18.5, 13.5; HRMS Calculated for C23H22N3 [M+H]
+




1-(1-(4-fluorophenyl)hept-2-ynyl)-1H-benzo[d][1,2,3]triazole (1.3i (N1)): 
1
H-NMR (600 MHz, 
CDCl3) δ 8.05 (d, J = 8.4 Hz, 1H), 7.53-7.49 (m, 3H), 7.37 (t, J = 7.2 Hz, 1H), 7.33 (t, J = 7.2 
Hz, 1H), 7.11 (s, 1H), 7.02 (t, J = 8.4 Hz, 2H), 2.34 (dt, J = 7.2 Hz, 2.4 Hz, 2H), 1.56 (quintet, J 
= 7.2 Hz, 2H), 1.41 (hextet, J = 7.2 Hz, 2H), 0.90 (t, J = 7.2 Hz, 3H); 
13
C-NMR (150 MHz, 
CDCl3) δ 16 .6, 162.0, 146.8, 131.9, 131.8, 131.2, 129.0, 128.9, 127.2, 124.0, 120.1, 115.8, 
115.6, 110.9, 90.6, 73.5, 54.8, 30.3, 21.9, 18.4, 13.4; HRMS Calculated for C19H19FN3 [M+H]
+
: 





1-(1-(4-fluorophenyl)hept-2-ynyl)-4-phenyl-1H-1,2,3-triazole (1.3j (N1)): 
1
H-NMR (600 
MHz, CDCl3) δ 7.89 (s, 1H), 7.82 (d, J = 7.2 Hz, 2H), 7.51-7.49 (m, 2H), 7.38 (t, J = 7.8 Hz, 
2H), 7.30 (t, J = 7.2 Hz, 1H), 7.04 (t, J = 7.8 Hz, 2H), 6.68 (s, 1H), 2.35 (dt, J = 7.2 Hz, 2.4 Hz, 
2H), 1.58 (quintet, J = 7.2 Hz, 2H), 1.45 (hextet, J = 7.2 Hz, 2H), 0.93 (t, J = 7.2 Hz, 3H); 
13
C-
NMR (150 MHz, CDCl3) δ 16 .7, 162.1, 148.0, 1 2.6, 1 2.5, 1 0. , 129.0, 128.9, 128.7, 128.2, 
125.7, 117.9, 115.9, 115.7, 90.4, 74.2, 55.7, 30.3, 22.0, 18.4, 13.5; HRMS Calculated for 
C21H21FN3 [M+H]
+
: 334.17195, Found: 334.17140. 
 
 
2-(1-(4-fluorophenyl)hept-2-ynyl)-4-phenyl-2H-1,2,3-triazole (1.3j (N2)): 
1
H-NMR (600 
MHz, CDCl3) δ 7.88 (s, 1H), 7.79 (d, J = 7.2 Hz, 2H), 7.57 (q, J = 4.8 Hz, 2H), 7.42 (t, J = 7.8 
Hz, 2H), 7.36-7.33 (m, 1H), 7.05 (t, J = 7.8 Hz, 2H), 6.64 (s, 1H), 2.36 (dt, J = 7.2 Hz, 2.4 Hz, 
2H), 1.58 (quintet, J = 7.2 Hz, 2H), 1.47 (hextet, J = 7.2 Hz, 2H), 0.93 (t, J = 7.2 Hz, 3H); 
13
C-
NMR (150 MHz, CDCl3) δ 16 .9, 162. , 148. , 1  .1, 1  .0, 1 2.0, 1 0.5, 129.7, 129.6, 129.0, 
128.7, 126.3, 115.9, 115.7, 89.9, 74.9, 60.3, 30.7, 22.2, 18.8, 13.8; HRMS Calculated for 
C21H21FN3 [M+H]
+





4-phenyl-1-(3-phenyl-1-p-tolylprop-2-ynyl)-1H-1,2,3-triazole (1.3k (N1)): 
1
H-NMR (600 
MHz, CDCl3) δ 7.94 (s, 1H), 7.82 (d, J = 7.2 Hz, 2H), 7.54 (d, J = 7.2 Hz, 2H), 7.50 (d, J = 8.4 
Hz, 2H), 7.41-7.36 (m, 5H), 7.31 (t, J = 7.2 Hz, 1H), 7.23 (d, J = 8.4 Hz, 2H), 6.94 (s, 1H), 2.37 
(s, 3H); 
13
C-NMR (150 MHz, CDCl3) δ 148.2, 1 9. , 1  .2, 1 1.9, 1 0.5, 129.7, 129. , 128.7, 
128.5, 128.2, 127.2, 125.7, 121.5, 118.1, 88.6, 83.3, 56.5, 21.1; HRMS Calculated for C24H20N3 
[M+H]
+
: 350.16572, Found: 350.16517. 
 
 
4-phenyl-2-(3-phenyl-1-p-tolylprop-2-ynyl)-2H-1,2,3-triazole (1.3k (N2)): 
1
H-NMR (600 
MHz, CDCl3) δ 7.92 (s, 1H), 7.8  (d, J = 7.2 Hz, 2H), 7.59-7.55 (m, 4H), 7.44 (t, J = 7.2 Hz, 
2H), 7.37-7.33 (m, 4H), 7.23 (d, J = 7.8 Hz, 2H), 6.89 (s, 1H), 2.37 (s, 3H); 
13
C-NMR (150 MHz, 
CDCl3) δ 148.1, 1 8.8, 1  .5, 1 2.0, 1 1.8, 1 0. , 129.4, 128.8, 128.7, 128.4, 128.2, 127.5, 
126.0, 122.1, 87.8, 83.9, 60.8, 21.1; HRMS Calculated for C24H20N3 [M+H]
+






1-(3-phenyl-1-p-tolylprop-2-ynyl)-1H-benzo[d][1,2,3]triazole (1.3l (N1)): 
1
H-NMR (600 MHz, 
CDCl3) δ 8.07 (d, J = 8.4 Hz, 1H), 7.62 (d, J = 8.4 Hz, 1H), 7.51-7.48 (m, 4H), 7.40-7.32 (m, 
6H), 7.18 (d, J = 7.8 Hz, 2H), 2.33 (s, 3H); 
13
C-NMR (150 MHz, CDCl3) δ 146.8, 1 8.9, 1 2.5, 
131.9, 131.4, 129.6, 129.1, 128.4, 127.3, 127.0, 124.0, 121.7, 120.1, 111.1, 88.9, 82.7, 55.6, 21.1; 
HRMS Calculated for C22H18N3 [M+H]
+
: 324.15007, Found: 324.14952. 
 
 
4-phenyl-1-(1-phenyl-3-(trimethylsilyl)prop-2-ynyl)-1H-1,2,3-triazole (1.3m (N1)): 
1
H-NMR 
(600 MHz, CDCl3) δ 7.87 (s, 1H), 7.81 (d, J = 8.4 Hz, 2H), 7.52 (d, J = 8.4 Hz, 2H), 7.42-7.37 
(m, 5H), 7.32(t, J = 8.4 Hz, 1H), 6.75 (s, 1H), 0.26 (s, 9H); 
13
C-NMR (150 MHz, CDCl3) δ 
148.2, 135.9, 130.5, 129.2, 129.0, 128.8, 128.2, 127.2, 125.7, 118.0, 98.8, 94.8, 56.6, -0.3; 
HRMS Calculated for C20H22N3Si [M+H]
+
: 332.15830, Found: 332.15790. 
 
 
4-phenyl-2-(1-phenyl-3-(trimethylsilyl)prop-2-ynyl)-2H-1,2,3-triazole (1.3m (N2)): 
1
H-NMR 
(600 MHz, CDCl3) δ 7.88 (s, 1H), 7.81 (d, J = 7.2 Hz, 2H), 7.58 (d, J = 7.8 Hz, 2H), 7.43-7.33 
(m, 6H), 6.69 (s, 1H), 0.25 (s, 9H); 
13
C-NMR (150 MHz, CDCl3) δ 148.1, 1 6.1, 1 1.9, 1 0.2, 
128.8, 128.7, 128.6, 128.5, 127.5, 126.0, 99.1, 93.6, 61.0, -0.3; HRMS Calculated for C20H22N3Si 
[M+H]
+





1-(1-phenyl-3-(trimethylsilyl)prop-2-ynyl)-1H-benzo[d][1,2,3]triazole (1.3n (N1)): 
1
H-NMR 
(600 MHz, CDCl3) δ 8.04 (d, J = 8.4 Hz, 1H), 7.57 (d, J = 8.4 Hz, 1H), 7.51 (d, J = 7.2 Hz, 2H), 
7.38-7.28 (m, 5H), 7.17 (s, 1H), 0.23 (s, 9H); 
13
C-NMR (150 MHz, CDCl3) δ 146.7, 1 5.1, 1 1. , 
128.8, 128.7, 127.1, 126.9, 123.9, 120.0, 111.1, 98.0, 95.0, 55.7, -0.4; HRMS Calculated for 
C18H20N3Si [M+H]
+
: 306.14265, Found: 306.14210. 
 
 
2-(1-(hex-1-ynyl)cyclohex-2-enyl)-4-phenyl-2H-1,2,3-triazole (1.3o (N2)): 
1
H-NMR (600 
MHz, CDCl3) δ 7.8  (s, 1H), 7.79 (d, J = 7.2 Hz, 2H), 7.42 (t, J = 7.8 Hz, 2H), 7.33 (t, J = 7.8 
Hz, 1H), 6.14 (s, 1H), 5.31-5.27 (m, 1H), 2.35-2.30 (m, 3H), 2.23-2.14 (m, 3H), 1.99-1.95 (m, 
1H), 1.77-1.72 (m, 1H), 1.51 (quintet, J = 7.2 Hz, 2H), 1.42 (sextet, J = 7.2 Hz, 2H), 0.92 (t, J = 
7.2 Hz, 3H); 
13
C-NMR (150 MHz, CDCl3) δ 147.7, 1 1.0, 1 0.8, 129. , 129.0, 128.5, 126.2, 
126.1, 90.8, 81.1, 61.0, 31.0, 29.7, 29.0, 22.2, 20.1, 19.2, 13.8; HRMS Calculated for C20H24N3 
[M+H]
+
: 306.19702, Found: 306.19678. 
 
 
1-(1-(hex-1-ynyl)cyclohex-2-enyl)-1H-benzo[d][1,2,3]triazole (1.3p (N1)): 
1
H-NMR (600 
MHz, CDCl3) δ 8.06 (d, J = 7.8 Hz, 1H), 7.57 (d, J = 8.4 Hz, 1H), 7.45 (t, J = 7.2 Hz, 1H), 7.35 
110 
 
(t, 7.2 Hz, 1H), 6.10 (s, 1H), 5.65-5.68 (m, 1H),  2.43-2.37 (m, 1H), 2.32 (t, J = 7.2 Hz, 3H), 
2.29-2.22 (m, 1H), 2.16-2.08 (m, 1H), 2.00-1.96 (m, 1H), 1.86-1.81 (m, 1H), 1.52 (quintet, J = 
7.2 Hz, 2H), 1.42 (sextet, J = 7.2 Hz, 2H), 0.92 (t, J = 7.2 Hz, 3H); 
13
C-NMR (150 MHz, CDCl3) 
δ 146.5, 1 2.1, 128.8, 127.0, 126.9, 12 .7, 120.1, 110.4, 91. , 80.5, 56.4,  0.7, 29.5, 28.9, 21.9, 
20.6, 19.0, 13.6; HRMS Calculated for C18H22N3 [M+H]
+
: 280.18137, Found: 280.18082. 
 
 
2-(1-(hex-1-ynyl)cyclohex-2-enyl)-2H-benzo[d][1,2,3]triazole (1.3p (N2)): 
1
H-NMR (600 
MHz, CDCl3) δ 7.87 (dd, J = 6.6 Hz, 3.0 Hz, 2H), 7.36 (dd, J = 6.6 Hz, 3.0 Hz, 2H), ), 6.19 (s, 
1H), 5.55-5.58 (m, 1H),  2.39-2.21 (m, 6H), 2.02-1.97 (m, 1H), 1.80-1.76 (m, 1H), 1.50 (quintet, 
J = 7.2 Hz, 2H), 1.41 (sextet, J = 7.2 Hz, 2H), 0.90 (t, J = 7.2 Hz, 3H); 
13
C-NMR (150 MHz, 
CDCl3) δ 144.4, 128.8, 126.7, 126.4, 118. , 91. , 81.0, 62.7,  0.9, 29.7, 29.6, 22.1, 20.1, 19.2, 
13.8; HRMS Calculated for C18H22N3 [M+H]
+
: 280.18137, Found: 280.18082. 
 
 
1-(1-((trimethylsilyl)ethynyl)cyclohex-2-enyl)-1H-benzo[d][1,2,3]triazole (1.3q (N1)): 
1
H-
NMR (600 MHz, CDCl3) δ 8.05 (d, J = 7.2 Hz, 1H), 7.54 (d, J = 8.4 Hz, 1H), 7.44 (t, J = 7.2 Hz, 
1H), 7.34 (t, J = 7.2 Hz, 1H), 6.23 (s, 1H), 5.65-5.61 (m, 1H), 2.44-2.37 (m, 1H), 2.33-2.30 (m, 
1H), 2.25-2.20 (m, 1H), 2.14-2.08 (m, 1H), 2.01-1.95 (m, 1H), 1.85-1.78 (m, 1H), 0.17 (s, 9H); 
13
C-NMR (150 MHz, CDCl3) δ 146.4, 1 2.1, 1 1.4, 127.1, 126. , 12 .8, 120.1, 110.2, 104.7, 
95.0, 56.1, 29.0, 28.7, 20.5, -0.2; HRMS Calculated for C17H22N3Si [M+H]
+





(E)-1-(1-phenyl-5-(trimethylsilyl)pent-1-en-4-yn-3-yl)-1H-benzo[d][1,2,3]triazole (1.3r (N1)): 
1
H-NMR (600 MHz, CDCl3) δ 8.07 (d, J = 7.8 Hz, 1H), 7.36-7.32 (m, 5H), 7.27-7.24 (m, 3H), 
6.92 (dd, J = 16.2 Hz, 6.6 Hz, 1H), 6.63 (d, J = 7.2 Hz, 1H), 5.65 (dd, J = 16.2 Hz, 1.8 Hz, 1H), 
0.18 (s, 9H); 
13
C-NMR (150 MHz, CDCl3) δ 146.4, 1 9.0, 1 6.6, 1 2.2, 129.0, 128.8, 127.4, 
127.3, 124.0, 120.2, 114.8, 110.2, 101.7, 97.8, 64.8, -0.3; HRMS Calculated for C20H22N3Si 
[M+H]
+






H-NMR (600 MHz, CDCl3) δ 8.02 (d, J = 8.4 Hz, 1H), 7.97 (dd, J = 7.8 Hz,1.8 Hz, 1H), 
7.60 (d, J = 8.4 Hz, 1H), 7.39 (t, J = 7.2 Hz, 1H), 7.34-7.28 (m, 3H), 7.05 (t, J = 7.8 Hz, 1H), 
6.80 (d, J = 8.4 Hz, 1H), 3.66 (s, 3H), 0.19 (s, 9H); 
13
C-NMR (150 MHz, CDCl3) δ 156.8, 146.0, 
131.9, 130.6, 129.2, 126.8, 123.5, 123.4, 120.5, 119.8, 110.9, 110.7, 99.1, 93.3, 55.4, 50.3, -0.4; 
HRMS Calculated for C19H22N3OSi [M+H]
+








NMR (600 MHz, CDCl3) δ 8.05 (d, J = 8.4 Hz, 1H), 7.65 (s, 1H), 7.49 (d, J = 8.4 Hz, 1H), 7.45 
(s, 1H), 7.41 (t, J = 7.2 Hz, 1H), 7.38-7.33 (m, 4H), 7.31-7.28 (m, 3H), 7.25-7.24 (m, 4H), 5.52 
(s, 2H); 
13
C-NMR (150 MHz, CDCl3) δ 146.1, 145.8, 1 7. , 1 4.2, 1 2.7, 129.2, 128.9, 128.8, 
128.6, 128.0, 127.6, 127.2, 124.1, 123.8, 120.0, 110.3, 59.5, 54.4; HRMS Calculated for 
C22H19N6 [M+H]
+






NMR (600 MHz, CDCl3) δ 7.87 (s, 1H), 7.74 (d, J = 7.2 Hz, 2H), 7.57 (s, 1H), 7.40 (t, J = 7.8 
Hz, 2H), 7.37-7.24 (m, 12H), 5.53 (s, 2H); 
13
C-NMR (150 MHz, CDCl3) δ 1 8.1, 1 4.5, 1 1.6, 
130.2, 129.1, 128.8, 128.7, 128.6, 128.5, 128.4, 128.0, 127.2, 126.0, 123.6, 65.5, 54.3; HRMS 
Calculated for C24H21N6 [M+H]
+






NMR (600 MHz, CDCl3) δ 8.02 (s, 1H), 7.81 (d, J = 7.8 Hz, 2H), 7.56 (s, 1H), 7.41-7.27 (m, 
13H), 7.17 (s, 1H), 5.53 (s, 2H); 
13
C-NMR (150 MHz, CDCl3) δ 1 7. , 1 4.0, 1 0.5, 129. , 
129.1, 129.0, 128.8, 128.7, 128.4, 128.2, 127.5, 125.7, 123.4, 119.9, 60.7, 54.5; HRMS 
Calculated for C24H21N6 [M+H]
+







H-NMR (600 MHz, CDCl3) δ 7.87 (s, 1H), 7.78 (d, J = 7.2 Hz, 2H), 7.50 (d, J = 9.0 Hz, 1H), 
7.45 (s, 1H), 7.43-7.39 (m, 4H), 7.37-7.26 (m, 9H), 6.67-6.60 (m, 2H), 5.51 (s, 2H); 
13
C-NMR 
(150 MHz, CDCl3) δ 147.6, 1 9. , 1 4.4, 1 1.1, 1 0.5, 129.1, 129.0, 128.8, 128.7, 128.6, 128. , 
128.1, 128.0, 127.0, 126.0, 122.8, 119.9, 66.2, 54.1; HRMS Calculated for C26H23N6 [M+H]
+
: 





NMR (600 MHz, CDCl3) δ 8.05 (d, J = 8.4 Hz, 1H), 7.55 (d, J = 8.4 Hz, 1H), 7.45 (s, 1H), 7.41-
7.32 (m, 5H), 7.28-7.27 (m, 2H), 6.55 (s, 1H), 5.77-5.74 (m, 1H), 5.52 (s, 2H), 2.68-2.66 (m, 2H), 
2.34-2.30 (m, 1H), 2.25-2.19 (m, 1H), 2.14-2.08 (m, 1H), 1.97-1.90 (m, 1H); 
13
C-NMR (150 
MHz, CDCl3) δ 148.1, 146.4, 1 4.5, 132.9, 132.2, 129.1, 128.8, 128.1, 127.0, 123.7, 121.4, 
120.1, 119.5, 110.3, 56.3, 54.2, 29.4, 25.9, 20.4; HRMS Calculated for C21H21N6 [M+H]
+
: 








H-NMR (600 MHz, CDCl3) δ 8.02 (d, J = 8.4 Hz, 1H), 7.84 (s, 1H), 7.59 (s, 1H), 7.53 (d, 
J = 8.4 Hz, 1H), 7.40 (t, J = 7.8 Hz, 1H), 7.36-7.30 (m, 4H), 7.28-7.23 (m, 4H), 6.89-6.85 (m, 
2H), 5.50 (s, 2H), 3.74 (s, 3H); 
13
C-NMR (150 MHz, CDCl3) δ 156.5, 145.9, 145.6, 1 4.4, 1 2.9, 
133.0, 129.1, 128.8, 128.7, 127.9, 127.2, 125.5, 123.8, 123.7, 120.8, 119.7, 110.8, 110.3, 55.5, 
54.2, 53.2; HRMS Calculated for C23H21N6O [M+H]
+






H-NMR (600 MHz, CDCl3) δ 8.04 (d, J = 8.4 Hz, 1H), 7.84 (s, 2H), 7.49 (d, J 
= 8.4 Hz, 1H), 7.40 (t, J = 7.2 Hz, 1H), 7.31 (quintet, J = 7.2 Hz, 2H), 7.22 (d, J = 7.8 Hz, 1H), 
6.92-6.89 (m, 2H), 6.22 (s, 2H), 3.78 (s, 3H), 1.17 (s, 9H); 
13
C-NMR (150 MHz, CDCl3) δ 177.5, 
156.5, 146.1, 145.8, 133.0, 130.2, 128.6, 127.3, 125.2, 125.1, 123.9, 120.9, 119.9, 110.9, 110.2, 
69.8, 55.6, 53.2, 38.8, 26.7; HRMS Calculated for C22H25N6O3 [M+H]
+






H-NMR (600 MHz, CDCl3) δ 7.89 (s, 1H), 7.79 (d, J = 7.2 Hz, 2H), 7.44 (s, 1H), 7.79 (t, J = 
7.8 Hz, 3H),  7.39-7.30 (m, 9H), 7.25 (d, J = 5.4 Hz, 1H), 7.04 (dd, J = 15.6 Hz, 5.4 Hz, 1H), 
6.54 (d, J = 15.6 Hz, 1H), 6.47 (d, J = 7.2 Hz, 1H), 5.50 (s, 2H); 
13
C-NMR (150 MHz, CDCl3) δ 
147.9, 138.1, 134.4, 131.3, 130.3, 129.1, 129.0, 128.9, 128.8, 128.7, 128.6, 128.4, 128.3, 128.1, 










Figure 1.   Perspective view of the molecular structure of C22H24N6O3 (molecule 1) with the 
atom labeling scheme.  The thermal ellipsoids are scaled to enclose 30% probability. 






Figure 2.   Perspective view of the molecular structure of C22H24N6O3 (molecule 1) with the 
atom labeling scheme.  The thermal ellipsoids are scaled to enclose 30% probability. 




Chapter Two: 1,2,3-triazoles work as X-factor to promote gold(I) complex in 
challenging chemical transformations - part I 
 
I. General Methods and Materials 
 
All of the reactions dealing with air and/or moisture-sensitive reactions were carried out under an 
atmosphere of nitrogen using oven/flame-dried glassware. Unless otherwise noted, all 
commercial reagents and solvents were obtained from the commercial provider and used without 
further purification. 1H NMR, 13C NMR, and 31P NMR, spectra were recorded on Agilent 400 
 Hz spectrometer. Chemical shifts were reported relative to internal tetramethylsilane (δ 0.00 
ppm) or C Cl  (δ 7.26 ppm) for 1H and C Cl  (δ 77.0 ppm) for 1 C. For the reaction 
monitoring, the reaction spectra were recorded using a ReactIR 15 from Mettler-Toledo 
AutoChem. 
 






The reaction was carried out as follows: a three-necked reaction vessel was fitted with a 
magnetic stirring bar. The IR probe was inserted through an adapter into the middle neck; the 
other two necks were capped by septa. The reaction vessel was charged with substrate 2.17 (29 
mg, 0.125 mmol) in dry DCE (1.2 mL) followed by immediate initiation of data collection. TA-
Au (2.13b) was then added and in situ IR spectra (2800-650cm-1) were recorded over the course 
of the reaction. The collected spectra were analyzed by iC IR 4.3 software and Origin 8.0. Peaks 
1211 cm-1 and 1757 cm-1 were used to calculate the concentration. The substrate was 
















II. Kinetic Profiles 
 
1. Determination of kinetic order of [2.13b] 
 
The reactions were monitored according to general procedure. Reaction conditions are: 2.17 





Figure S3. Determination of kinetic order of [2.13b]. 
 
2. Determination of kinetic order of [2.17] 
 
The reactions were monitored according to general procedure. Reaction conditions are: 2.17 





Figure S4. Determination of kinetic order of [2.17]. 
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3. Variable temperature experiment 
 
The reactions were monitored according to general procedure. Reaction conditions are: 2.17 





Figure S5. Kinetics profile at different temperatures. 
 
4. Hammett plot with various modified TA-Au catalysts 
 
The reactions were monitored according to general procedure. Reaction conditions are: 2.17 











P NMR Experiments 
 
Variable temperature experiment with catalyst 4 
 
A NMR tube containing catalyst 2.13b (0.025 M) in CD2Cl2 (0.7 mL) was inserted in NMR 
machine. 
31









Figure S7. Variable temperature experiment with catalyst 2.13b. 
 
31
P NMR monitoring of the reaction progress 
 
A NMR tube was charged with catalyst 2.13b (2 mol %, 0.002 M) and 2.17 (1 equiv.) in CD2Cl2 
(0.6 mL). The tube was shaken periodically and NMR spectrum was taken at 0 min, 5 min, 15 









IV. Catalyst Characterization 
 






A 20 mL screw-cap vial was charged with Ph
3
PAuCl (1 equiv.) and benzotriazole derivative (1 
equiv.) in dry DCM (0.1 M), followed by the addition of AgOTf (1 equiv.). The vial was allowed 
to stir at ambient temperature for 6-12h, and concentrated in vacuo to give the product in >90% 
yield. Pure gold catalyst was obtained through diffusion of hexanes into DCM solution. 
 
 
1H-N R (400  Hz, C Cl ) δ 8.25-8.22 (m, 1H), 7.95-7.93 (m, 1H), 7.84-7.80 (m, 2H), 7.76-
7.74 (m, 2H), 7.68-7.51 (m, 15H), 7.22-7.20 (m, 2H), 3.93 (s, 3H). 13C-NMR (100 MHz, CDCl3) 
δ 161. , 14 .4, 1 4.1, 1  .9, 132.9, 129.8, 129.7, 129.0, 126.7, 126.1, 126.1, 125.2, 117.1, 115.5, 
112.2, 55.8. 31P-N R (162 Hz, C Cl ) δ  1.9. 
 
 
1H-N R (400  Hz, C Cl ) δ 8.28-8.26 (m, 1H), 7.98-7.95 (m, 1H), 7.87-7.81 (m, 2H), 7.73-
7.71 (m, 2H), 7.68-7.58 (m, 15H), 7.53-7.51 (m, 2H), 2.51 (s, 3H). 13C-NMR (100 MHz, CDCl3) 
δ 14 .5, 141.6, 1 4.1, 1 4.0, 1 2.9, 1 1.1, 1 1.0, 129.9, 129.7, 129.2, 126.8, 126.1, 123.5, 119.2, 





1H-N R (400  Hz, C Cl ) δ 8. 0-8.28 (m, 1H), 7.98-7.95 (m, 1H), 7.86-7.80 (m, 4H), 7.75-
7.71 (m, 2H), 7.69-7.58 (m, 15H), 7.54-7.49 (m, 1H). 13C-N R (100  Hz, C Cl ) δ 1 5.1, 
134.2, 134.1, 132.9, 131.1, 130.9, 130.5, 129.9, 129.8, 128.9, 126.8, 126.2, 123.7, 117.8, 112.0. 
31P-N R (162 Hz, C Cl ) δ  0.4. 
 
 
1H-N R (400  Hz, C Cl ) δ 8.26-8.22 (m, 1H), 7.98-7.95 (m, 1H), 7.92-7.87 (m, 2H), 7.83-
7.79 (m, 2H), 7.66-7.57 (m, 15H), 7.44-7.38 (m, 2H). 13C-N R (100  Hz, C Cl ) δ 143.8, 
134.2, 134.1, 132.9, 131.2, 129.9, 129.9, 129.8, 128.9, 126.9, 126.2, 126.1, 126.0, 117.8, 112.1. 
31P-N R (162 Hz, C Cl ) δ  0. . 
 
 
1H-N R (400  Hz, C Cl ) δ 8.5  (d, J = 8.8 Hz, 2H), 8.25 (d, J = 8.4 Hz, 3H), 8.18 (d, J = 
8.0 Hz, 1H), 7.90-7.81 (m, 2H), 7.66-7.53(m, 15H). 13C-N R (100  Hz, C Cl ) δ 148. , 
143.7, 139.7, 134.1, 134.0, 132.8, 132.0, 129.8, 129.7, 126.8, 126.1, 125.8, 124.6, 117.3, 112.5. 




V. DFT Calculation 
 
To examine the structural and energy aspects of this reaction, density function theory (DFT) 
theoretical calculations were carried out with the Gaussian 03 program. In brief, the geometrical 
optimizations and single point energy calculations were performed using Becke’s three-
parameter exchange functional and the nonlocal correlation functional of Lee, Yang and Parr 
(B3LYP) with the 6-311G basis set. 
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Chapter Three: 1,2,3-triazoles work as X-factor to promote gold(I) complex in 
challenging chemical transformations - part II 
 
I. General Methods and Materials 
 
All of the reactions dealing with air and/or moisture-sensitive reactions were carried out under an 
atmosphere of nitrogen using oven/flame-dried glassware and standard syringe/septa techniques. 
Unless otherwise noted, all commercial reagents and solvents were obtained from the 
commercial provider and used without further purification. 
1
H NMR and 
13
C NMR spectra were 
recorded on Varian 600 MHz spectrometers. Chemical shifts were reported relative to internal 
tetramethylsilane ( 0.00 ppm) or CDCl3 ( 7.26 ppm) for 
1
H and CDCl3 ( 77.0 ppm) for 
13
C. 
Flash column chromatography was performed on 230-430 mesh silica gel. Analytical thin layer 
chromatography was performed with precoated glass baked plates (250μ) and visualized by 
fluorescence and by charring after treatment with potassium permanganate stain. HRMS were 
recorded on LTQ-FTUHRA spectrometer.  
 
Substrates 3.18 and 3.25 were synthesized according to the literature as below:  
(1). Li, H.; Petersen, J.; Wang, K. K. J. Org. Chem. 2001, 66, 7804-7810 
(2). Yu, M.; Zhang, G.; Zhang, L. Org. Lett. 2007, 9, 2147-2150.  
(3). Marion, N.; Carlqvist, P.; Gealageas, R.; Fremont, P.; Maseras, F.; Nolan, S. P. Chem. Eur. J. 
2007, 13, 6437-6451.  
(4). Nonoshita, K.; Banno, H.; Maruoka, K.; Yamamoto, H. J. Am. Chem. Soc. 1990, 112, 316-
322.  
(5). (a) Sherry, B. D.; Toste, F. D. J. Am. Chem. Soc. 2004, 126, 15978-15979. (b) Sherry, B. D.; 
Maus, L.; Laforteza, B. N.; Toste, F. D. J. Am. Chem. Soc. 2006, 128, 8132-8133. (c) Mauleon, 







Procedure for the synthesis of fluorenyl ethanol 6a. 
 
 
To a solution of 3.18a (67 mg, 0.2 mmol) in dry CH2Cl2 (2 mL, 0.1 M), was added Au(I) catalyst 
(4.4 mg, 0.006 mol, 3.0 mol%) at 0 °C. The reaction mixture was stirred at 0 °C for 4 hours. 
Temperature was slowly raised to RT, reaction mixture was stirred and monitored by TLC. After 
the reaction was completed (6-16 h), NaBH4 and MeOH were treated. Upon completion, the 
solvent was removed under reduced pressure and the residue was purified by flash 










Entry conc. (M) temp (
o
C) time conv. (%) yield (%)
a
 
1 0.1 rt 16 h >99 47 
2 0.1 rt 16 h 95 26 
3 0.1 rt 16 h 97 21 
4 0.1 rt 16 h >99 32 
5 0.1 rt 16 h >99 15 
6 0.1 rt 16 h 97 41 
7 0.1 rt 16 h 32 0 
8 0.1 rt 16 h 44 0 
9 0.1 rt 16 h >99 65 
 
General reaction condition: 4c (0.2 mmol), catalyst (3 mol%) in solvent (2 mL), the reactions were 
monitored by TLC, 0 oC to rt. a Conversion and yields were determined by NMR with 1,3,5-




III. Compounds Characterization 
 
1-(3-(2-(2-phenylethynyl)phenyl)-1-(vinyloxy)prop-2-ynyl)benzene (3.18a) was purified by 
flash chromatography (Hexane-EtOAc, v/v 15/1) as light yellow liquid; 
1
H-NMR (600 MHz, 
CDCl3) δ 7.66 (dd, J = 4.8 Hz, 2.4 Hz, 2H), 7.54 (dd, J = 12 Hz, 6.6 Hz, 2H), 7.45 (dd, J = 7.8 
Hz, 1.8 Hz, 2H), 7.34-7.29 (m, 8H), 6.63 (dd, J = 13.8 Hz, 6.6 Hz, 1H), 5.83 (s, 1H), 4.59(dd, J 
= 13.8 Hz, 1.8 Hz, 1H), 4.17 (dd, J = 6.6 Hz, 2.4 Hz, 1H); 
13
C-NMR (150 MHz, CDCl3) δ 149.4, 
137.5, 132.3, 131.9, 131.8, 128.7, 128.6, 128.5, 128.4, 128.2, 127.9, 127.6, 126.0, 124.7, 123.0; 
HRMS Calculated for C25H18O [M+H]
+
: 335.1436, Found: 335.1431. 
 
  
1-methoxy-4-(3-(2-(2-phenylethynyl)phenyl)-1-(vinyloxy)prop-2-ynyl)benzene (3.18b) was 
purified by flash chromatography (Hexane- EtOAc, v/v 15/1) as light yellow liquid; 
1
H-NMR 
(600 MHz, CDCl3) δ 7.57 (d, J = 9.0 Hz, 2H), 7.53(dd, J = 12.0 Hz, 4.2 Hz, 2H), 7.45 (dd, J = 
4.8 Hz,  1.8 Hz, 2H), 7.34-7.29 (m, 5H), 6.78 (d, J = 9.0 Hz, 2H), 6.60 (dd, J = 13.8 Hz, 6.6 Hz, 
1H), 5.76 (s, 1H), 4.56 (dd, J = 14.4 Hz, 2.4 Hz, 1H), 4.14 (dd, J = 6.6 Hz, 1.8 Hz, 1H), 3.75 (s, 
3H); 
13
C-NMR (150 MHz, CDCl3) δ 160.1, 149.6, 1 2.5, 1 2.1, 1 2.0, 129.9, 129.4, 128.7, 
128.6, 128.5, 128.2, 126.3, 124.9, 123.3, 114.2, 93.7, 90.8, 90.2, 88.2, 87.1, 71.3; HRMS 
Calculated for C26H20O2 [M+H]
+





1-nitro-3-(3-(2-(2-phenylethynyl)phenyl)-1-(vinyloxy)prop-2-ynyl)benzene (3.18c) was 
purified by flash chromatography (Hexane- EtOAc, v/v 15/1) as light yellow liquid; 
1
H-NMR 
(600 MHz, CDCl3) δ 8.45 (s, 1H), 8.11 (dd, J = 7.8 Hz, 2.4 Hz, 1H), 7.99 (d, J = 8.4Hz, 1H), 
7.52 (dd, J = 13.2 Hz, 7.8 Hz, 2H), 7.40 (d, J = 6.0 Hz, 2H), 7.38-7.27 (m, 6H), 6.60 (dd, J = 
13.8 Hz, 6.6 Hz, 1H), 5.87 (s, 1H), 4.61 (dd, J = 14.4 Hz, 2.4 Hz, 1H), 4.30 (dd, J = 6.6 Hz, 2.4 
Hz, 1H); 
13
C-NMR (150 MHz, CDCl3) δ 149.0, 148.2, 1 9.7, 1  .4, 1 2.2, 1 1.9, 1 1.6, 129.6, 
128.9, 128.6, 128.3, 128.0, 126.2, 124.0, 123.5, 122.8, 122.4, 93.6, 91.6, 88.3, 87.9, 87.6, 69.9; 
HRMS Calculated for C25H17NO3 [M+H]
+
: 380.1287, Found: 380.1282. 
 
 
3-(3-(2-(2-phenylethynyl)phenyl)-1-(vinyloxy)prop-2-ynyl)benzonitrile (3.18d) was purified 
by flash chromatography (Hexane- EtOAc, v/v 15/1) as light yellow liquid; 
1
H-NMR (600 MHz, 
CDCl3) δ 7.91-7.89 (m, 2H), 7.56 (t, J = 7.8 Hz, 2H), 7.52 (d, J = 6.6 Hz, 1H), 7.43 (dd, J = 7.8 
Hz, 1.2 Hz, 2H), 7.37-7.30 (m, 6H), 6.58 (dd, J = 13.8 Hz, 6.6 Hz, 1H), 5.82 (s, 1H), 4.60 (dd, J 
= 14.4 Hz, 2.4 Hz, 1H), 4.23 (dd, J = 6.6 Hz, 2.4 Hz, 1H); 
13
C-NMR (150 MHz, CDCl3) δ 149.0, 
139.2, 132.2, 132.0, 131.7, 131.6, 130.9, 129.4, 128.9, 128.6, 128.3, 128.0, 126.2, 124.0, 122.8, 
118.4, 112.7, 93.6, 91.5, 88.4, 87.9, 87.7, 70.0; HRMS Calculated for C26H17NO [M+H]
+
: 





1-fluoro-3-(3-(2-(2-phenylethynyl)phenyl)-1-(vinyloxy)prop-2-ynyl)benzene (3.18e) was 
purified by flash chromatography (Hexane- EtOAc, v/v 8/1) as light yellow liquid; 
1
H-NMR 
(600 MHz, CDCl3) δ 7.55 (dd, J = 16.2 Hz, 7.2 Hz, 2H), 7.47-7.44 (m, 3H), 7.39-7.23 (m, 7H), 
7.02 (td, J = 9.6 Hz, 2.4 Hz, 1H), 6.62 (dd, J = 14.4 Hz, 6.6 Hz, 1H), 5.82 (s, 1H), 4.61 (dd, J = 
13.8 Hz, 2.4 Hz, 1H), 4.20 (dd, J = 6.6 Hz, 1.8 Hz, 1H); 
13
C-NMR (150 MHz, CDCl3) δ 16 .6, 
162.0, 149.2, 140.0, 139.9, 132.3, 131.9, 131.7, 130.2, 130.1, 128.6, 128.5, 128.3, 127.9, 126.1, 
124.4, 123.1, 123.0, 122.9, 115.6, 115.5, 114.5, 114.4, 93.6, 91.1, 89.1, 87.8, 87.3, 70.5; HRMS 
Calculated for C25H17OF [M+H]
+




was purified by flash chromatography (Hexane- EtOAc, v/v 8/1) as light yellow liquid; 
1
H-NMR 
(600 MHz, CDCl3) δ 7.62 (dd, J = 9.0 Hz, 3.0 Hz, 1H), 7.53 (t, J = 7.8 Hz, 1H), 7.52-7.47 (m, 
4H), 7.35-7.31 (m, 4H), 7.29 (td, J = 7.8 Hz, 1.8 Hz, 1H), 6.92-6,89 (m, 1H), 6.59 (dd, J = 14.4 
Hz, 6.6 Hz, 1H), 6.06 (s, 1H), 4.57 (dd, J = 14.4 Hz, 2.4 Hz, 1H), 4.21 (dd, J = 6.6 Hz, 2.4 Hz, 
1H); 
13
C-NMR (150 MHz, CDCl3) δ 162.9, 161. , 149.2, 1 9.1, 1 9.0, 1 4.1, 1 4.0, 1 2.2, 
131.9, 131.7, 128.7, 128.6, 128.4, 128.2, 127.9, 126.2, 124.3, 122.9, 117.4, 117.3, 117.0, 116.7, 








2-(3-(2-(2-phenylethynyl)phenyl)-1-(vinyloxy)prop-2-ynyl)naphthalene (3.18g) was purified 
by flash chromatography (Hexane-EtOAc, v/v 8/1) as light yellow liquid; 
1
H-NMR (600 MHz, 
CDCl3) δ 8.10 (s, 1H), 7.82 (d, J = 8.4 Hz, 1H), 7.80-7.75 (m, 3H), 7.56 (d, J = 8.4 Hz, 2H), 
7.51-7.45 (m, 2H), 7.35-7.25 (m, 5H), 7.14 (t, J = 7.8 Hz, 2H), 6.68 (dd, J = 14.4 Hz, 6.6 Hz, 
1H), 5.99 (s, 1H), 4.64 (dd, J = 13.8 Hz, 2.4 Hz, 1H), 4.20 (dd, J = 6.6 Hz, 1.8 Hz, 1H); 
13
C-
NMR (150 MHz, CDCl3) δ 149.4, 1 5.0, 1  .4, 1  .1, 1 2. , 1 1.9, 128.7, 128.5, 128. , 128.1, 
127.9, 127.7, 126.7, 126.4, 126.2, 126.1, 125.1, 124.6, 122.9, 93.6, 90.9, 89.8, 87.9, 87.2, 71.6; 
HRMS Calculated for C29H20O [M+H]
+
: 385.1592, Found: 385.1587. 
 
 
2-(5-phenyl-11H-benzo[b]fluoren-11-yl)ethanol (3.21a) was purified by flash chromatography 
(Hexane- EtOAc, v/v 8/1) as yellow liquid; 
1
H-NMR (600 MHz, CDCl3) δ 8.00 (s, 1H), 7.6 -
7.56 (m, 3H), 7.53 (dd, J = 7.2 Hz, 6.6 Hz, 2H), 7.48-7.44 (m, 2H), 7.41-7.36 (m, 2H), 7.25 (t, J 
= 7.2 Hz, 1H), 7.03 (t, J = 6.0 Hz, 1H), 4.67 (d, J = 7.8 Hz, 1H), 4.36 (t, J = 6.0 Hz, 1H), 3.73-
3.68 (m, 2H), 2.45-2.40 (m, 2H); 
13
C-NMR (150 MHz, CDCl3) δ 147.7, 144.8, 140.6, 1 8.8, 
136.8, 133.7, 132.8, 132.7, 130.1, 130.0, 129.1, 127.8, 127.7, 127.3, 126.9, 126.3, 125.5, 124.3, 
123.7, 122.5, 60.2, 43.7, 36.9; HRMS Calculated for C25H20O [M+H]
+






2-(7-methoxy-5-phenyl-11H-benzo[b]fluoren-11-yl)ethanol (3.21b) was purified by flash 
chromatography (Hexane- EtOAc, v/v 8/1) as yellow liquid; 
1
H-NMR (600 MHz, CDCl3) δ 7.54-
7.53 (m, 1H), 7.48-7.45 (m, 3H), 7.41 (d, J = 9.0 Hz, 2H), 7.33-7.30 (m, 3H), 7.28-7.25 (m, 2H), 
6.76 (d, J = 9.0 Hz, 2H), 4.11 (t, J = 7.2 Hz, 1H), 3.96-3.92 (m, 1H), 3.80-3.75 (m, 4H), 2.10-
2.04 (m, 1H); 
13
C-NMR (150 MHz, CDCl3) δ 158.4, 1  .5, 1 2.0, 1 1.9, 1 1.7, 128.5, 128. , 
128.0, 127.6, 125.9, 125.7, 123.2, 114.0, 95.4, 92.9, 88.4, 82.4, 60.8, 55.2, 41.2, 34.4; HRMS 
Calculated for C26H22O2 [M+H]
+
: 367.1698, Found: 367.1693. 
 
 
2-(8-nitro-5-phenyl-11H-benzo[b]fluoren-11-yl)ethanol (3.21c) was purified by flash 
chromatography (Hexane- EtOAc, v/v 8/1) as yellow liquid; 
1
H-NMR (600 MHz, CDCl3) δ 8.09 
(s, 1H), 8.06 (d, J = 7.2 Hz, 1H), 7.58-7.42 (m, 7H), 7.31 (d, J = 7.2 Hz, 1H), 7.27 (t, J = 7.2 Hz, 
1H), 7.00 (t, J = 7.2 Hz, 1H), 6.15 (d, J = 7.2 Hz, 1H), 4.37 (t, J = 6.0 Hz, 1H), 3.73 (t, J = 6.6 
Hz, 2H), 2.44-2.34 (m, 2H); 
13
C-NMR (150 MHz, CDCl3) δ 149.6, 148.1, 146.7, 140.8, 1 9.8, 
136.4, 131.8, 131.1, 130.6, 128.7, 128.6, 128.5, 127.2, 124.5, 124.3, 123.9, 123.3, 122.7, 122.2, 
60.0, 43.5, 36.8; HRMS Calculated for C25H19NO3 [M+H]
+





11-(2-hydroxyethyl)-5-phenyl-11H-benzo[b]fluorene-8-carbonitrile (3.21d) was purified by 
flash chromatography (Hexane- EtOAc, v/v 8/1) as yellow liquid; 
1
H-NMR (600 MHz, CDCl3) δ 
8.14 (d, J = 7.8 Hz, 1H), 8.07 (s, 1H), 7.92 (d, J = 8.4 Hz, 1H), 7.68 (t, J = 7.2 Hz, 1H), 7.62 (q, 
J = 7.2 Hz, 2H), 7.52-7.48 (m, 3H), 7.44 (d, J = 6.0 Hz, 1H), 7.28 (t, J = 7.2 Hz, 1H), 7.03 (t, J = 
7.2 Hz, 1H), 6.29 (d, J = 7.8 Hz, 1H), 4.37 (t, J = 6.0 Hz, 1H), 3.73 (t, J = 6.6 Hz, 2H), 2.44-2.36 
(m, 2H); 
13
C-NMR (150 MHz, CDCl3) δ 148.0, 146.2, 140.2, 1 9.9, 1 7.7, 1 6.8, 1  .7, 1  .0, 
132.8, 131.0, 129.5, 129.2, 128.2, 127.3, 124.4, 123.7, 109.5, 102.9, 60.0, 43.5, 36.7; HRMS 
Calculated for C26H19NO [M+H]
+
: 362.1545, Found: 362.1539. 
 
 
2-(8-fluoro-5-phenyl-11H-benzo[b]fluoren-11-yl)ethanol (3.21e) was purified by flash 
chromatography (Hexane-EtOAc, v/v 8/1) as yellow liquid; 
1
H-NMR (600 MHz, CDCl3) δ 8.00 
(s, 1H), 7.70 (d, J = 8.4 Hz, 1H), 7.55-7.51 (m, 4H), 7.47-7.45 (m, 1H), 7.41-7.36 (m, 2H), 7.24 
(t, J = 7.2 Hz, 1H), 7.27-6.89 (m, 2H), 6.17 (d, J = 7.8 Hz, 1H), 4.34 (t, J = 6.0 Hz, 1H), 3.74-
3.67 (m, 2H), 2.44-2.37 (m, 2H); 
13
C-NMR (150 MHz, CDCl3) δ 175.8, 161.1, 159.4, 147.8, 
145.8, 141.4, 140.5, 138.6, 135.1, 131.1, 128.7, 128.6127.7, 127.5, 127.2, 125.7, 124.4, 124.3, 






2-(9-bromo-6-fluoro-5-phenyl-11H-benzo[b]fluoren-11-yl)ethanol (3.21f) was purified by 
flash chromatography (Hexane-EtOAc, v/v 8/1) as yellow liquid; 
1
H-NMR (600 MHz, CDCl3) δ 
8.44 (s, 1H), 7.69 (dd, J = 8.4 Hz, 4.2 Hz, 1H), 7.56-7.53 (m, 4H), 7.44-7.42 (m, 1H), 7.38-7.35 
(m, 1H), 7.27 (t, J = 7.2 Hz, 1H), 7.00 (t, J = 7.8 Hz, 1H), 6.90 (dd, J = 12.6 Hz, 8.4 Hz, 1H), 




C-NMR (150 MHz, CDCl3) δ 160.6, 158.9, 147.9, 147.4, 140.7, 140.6, 1 9.9, 1 9. , 1 2.6, 
131.6, 129.3, 129.2, 128.7, 128.6, 128.5, 128.4, 128.0, 127.5, 127.1, 124.4, 124.3, 123.7, 123.6, 
122.2, 117.3, 117.2, 111.7, 111.5, 60.1, 43.9, 36.9; HRMS Calculated for C25H18OFBr [M+H]
+
: 
433.0603, Found: 433.0598. 
 
 
2-(13-phenyl-8H-indeno[2,1-b]phenanthren-8-yl)ethanol (3.21g) was purified by flash 
chromatography (Hexane-EtOAc, v/v 8/1) as yellow liquid; 
1
H-NMR (600 MHz, CDCl3) δ 7.9  
(s, 1H), 7.79 (d, J = 7.2 Hz, 1H), 7.74-7.72 (m, 2H), 7.62 (d, J = 8.4 Hz, 1H), 7.55-7.54 (m, 1H), 
7.51-7.49 (m, 1H), 7.46-7.42 (m, 2H), 7.36 (d, J = 8.4 Hz, 2H), 7.31-7.24 (m, 4H), 7.16 (t, J = 
7.8 Hz, 1H), 4.34 (t, J = 7.2 Hz, 1H), 4.01-3.97 (m, 1H), 3.83-3.79 (m, 1H), 2.19 (q, J = 6.0 Hz, 
2H); 
13
C-NMR (150 MHz, CDCl3) δ 1 8.8, 1  .5, 1 2.5, 1 2.0, 1 1.9, 131.6, 128.5, 128.3, 
128.2, 128.0, 127.8, 127.7, 127.6, 126.1, 126.0, 125.9, 125.8, 125.7, 125.6, 123.1, 95.0, 93.0, 
88.4, 82.7, 60.7, 40.9, 35.4; HRMS Calculated for C29H22O [M+H]
+




butyl)dimethylsilane (3.25a) was purified by flash chromatography (Hexane-EtOAc, v/v 15/1) 
as light yellow liquid; 
1
H-NMR (600 MHz, CDCl3) δ 7.74 (d, J = 7.8 Hz, 1H), 7.50-7.47 (m, 3H), 
7.37 (dd, J = 7.8 Hz, 1.8 Hz, 1H), 7.33 (t, J = 7.8 Hz, 1H),  7.28-7.25 (m, 4H), 7.23-7.19 (m, 3H), 
6.54 (d, J = 12.6 Hz, 1H), 6.15 (s, 1H), 5.22 (q, J = 12.6 Hz, 1H), 4.05 (d, J = 6.6 Hz, 2H), 0.87-
0.66 (m, 9H), 0.09-0.05 (m, 6H); 
13
C-NMR (150 MHz, CDCl3) δ 146. , 1 9. , 1 2.2, 1 1.8, 
131.6, 128.8, 128.6, 128.5, 128.4, 128.2, 127.5, 123.0, 122.4, 122.3, 107.0, 94.9, 88.0, 86.5, 85.8, 
70.0, 61.0, 26.2, 26.0, 18.3, -5.0; HRMS Calculated for C32H34O2Si [M+H]
+






Trimethyl(2-(2-(3-phenyl-1-(vinyloxy)prop-2-ynyl)phenyl)ethynyl)silane (3.25b) was 
purified by flash chromatography (Hexane- EtOAc, v/v 15/1) as light yellow liquid; 
1
H-NMR 
(600 MHz, CDCl3) δ 7.8  (d, J = 7.8 Hz, 1H), 7.52 (d, J = 7.8 Hz, 1H), 7.50-7.48 (m, 2H), 7.41 
(td, J = 7.2 Hz, 1.8 Hz, 1H), 7.34-7.30 (m, 4H), 6.60 (dd, J = 13.8 Hz, 6.6 Hz, 1H), 6.21 (s, 1H), 
4.59 (dd, J = 13.8 Hz, 2.4 Hz, 1H), 4.23 (dd, J = 6.6 Hz, 2.4 Hz, 1H), 0.30-0.28 (m, 9H); 
13
C-
NMR (150 MHz, CDCl3) δ 150.1, 150.0, 1 9.7, 1 2.4, 1 1.8, 129.0, 128.6, 128.5, 128.2, 127.4, 
122.4, 122.3, 101.9, 100.3, 90.0, 87.9, 85.7, 69.0, 68.9, -0.07; HRMS Calculated for C22H22OSi 
[M+H]
+




was purified by flash chromatography (Hexane-EtOAc, v/v 8/1) as yellow liquid; 
1
H-NMR (600 
MHz, CDCl3) δ 7.56-7.53 (m, 3H), 7.49-7.47 (m, 3H), 7.37-7.33 (m, 4H), 7.28-7.25 (m, 2H), 
7.21 (t, J = 7.8 Hz, 2H), 4.04 (dd, J = 9.6 Hz, 4.2 Hz, 1H), 3.98-3.91 (m, 2H), 3.85 (t, J = 9.6 Hz, 
1H), 3.24-3.19 (m, 1H), 2.86 (br, 1H); 
13
C-NMR (150 MHz, CDCl3) δ 1 5.2, 1 5.1, 1 2.7, 1 1.6, 
128.7, 128.6, 128.4, 128.3, 127.5, 127.1, 126.4, 126.2, 123.1, 121.4, 108.3, 97.3, 94.5, 87.4, 66.4, 
66.0, 43.9, 25.8, 18.2, -5.5; HRMS Calculated for C32H36O2Si [M+H]
+






5-(2-(2-(trimethylsilyl)ethynyl)phenyl)-3-phenylpenta-3,4-dien-1-ol (3.26b) was purified by 
flash chromatography (Hexane-EtOAc, v/v 8/1) as yellow liquid; 
1
H-NMR (600 MHz, CDCl3) δ 
7.47 (q, J = 7.8 Hz, 4H), 7.34 (t, J = 7.8 Hz, 2H), 7.27-7.22 (m, 3H), 7.16-7.14 (m, 2H), 3.93 (t, J 
= 6.0 Hz, 2H), 2.92-2.83 (m, 2H), 0.32-0.26 (m, 9H); 
13
C-NMR (150 MHz, CDCl3) δ 207.0, 
135.7, 135.3, 133.1, 128.9, 128.6, 127.4, 126.9, 126.2, 126.1, 121.2, 106.9, 103.0, 99.7, 96.6, 
61.1, 33.3, 0.00; HRMS Calculated for C22H24OSi [M+H]
+






Chapter Four: 1,2,3-triazoles work as X-factor to promote gold(I) complex in 
challenging chemical transformations - part III 
 
I. General Methods and Materials 
 
All of the reactions dealing with air and/or moisture-sensitive reagnets were carried out under an 
atmosphere of nitrogen using oven/flame-dried glassware and standard syringe/septa techniques. 
Unless otherwise noted, all commercial reagents and solvents were obtained from the 








P NMR spectra 
were recorded on Agilent 400 MHz spectrometers, (400 MHz, 100 MHz, 128 MHz and 160 
MHz) at a temperature of 300 K. NMR multiplicities are abbreviated as follows: s = singlet, d = 
doublet, m = multiplet. Chemical shifts (δ) and coupling constants ( ) are expressed in ppm and 
Hz respectively. NMR chemical shifts were reported relative to internal tetramethylsilane ( 0.00 
ppm) or CDCl3 ( 7.26 ppm) for 
1
H and CDCl3 ( 77.0 ppm) or CD3CN ( 118.3 ppm) for 
13
C. 
Flash column chromatography was performed on 230-430 mesh silica gel. Analytical thin layer 
chromatography was performed with precoated glass baked plates (250μ) and visualized by 
fluorescence and by charring after treatment with potassium permanganate stain. HRMS were 
recorded on LTQ-FTUHRA spectrometer.  
 
Substrates were synthesized according to the literature as below:  
[1]. L. N. Lee, A. S. C. Chan and F. Y. Kwong, Eur. J. Org. Chem. 2008, 3403-3406. 
[2]. Sylvester, K. T.; Chirik, P. J. J. Am. Chem. Soc. 2009, 131, 8772-8774.  
[3]. W. Hess, J. W. Burton, Chem. Eur. J. 2010, 16, 12303-12306. 
[4]. J. C. Sheehan, W. A. Bolhofer, J. Am. Chem. Soc. 1950, 72, 2786-2788. 
 










To freshly distilled dichloromethane (3 ml) was successively added LAuCl, 0.3 mmol 1.0 eq., L 
= PPh3 (Triphenylphosphine), IPr (1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene), XPhos 
(2-Dicyclohexylphosphino-2′,4′,6′-triisopropylbiphenyl), 1H-benzo[d][1,2,3]triazole (35.7 mg, 




). The reaction mixture 
was stirred at room temperature for 6 hours and was slowly filtered through celite pad twice to 
remove the AgCl and excess amount of the AgX. The clear solution was concentrated under 
reduced pressure. The resulting crude product was purified by recrystalization from 




 as white solid. 
 
31P NMR sample preparation 
 
To a NMR sample tube with a sealed capillary tube containing H3PO4/D2O (1M) solution as 
internal standard for chemical shift ( 0.00 ppm) and integration (value = 100), was successively 
added gold(I) complex/CDCl3 solution (0.052 M, 0.5 mL), and 4.38b/CDCl3 solution (0.39 M, 
0.2 mL). Then the tube was sealed and shaked. 
 




To 31.5 mL hydrazine monohydrate was added 2-(3-phenylprop-2-ynyl)isoindoline-1,3-dione 
(1.044 g, 4 mol). The reaction mixture was stirred at 45 °C. The reaction was monitored by TLC. 
After the reaction was completed (25 min) the mixture was cooled to room temperature and was 
poured to a vessel containing dichloromethane (15 mL). The mixture was extracted with 
dichloromethane (3 × 10mL) and the combined organic phase was washed with brine (2 × 10mL), 
dried over Na2SO4 and was concentrated under rotary vacuum evaporator. The resulting crude 
product was added dropwise into a HCl (1M) solution in EtOH and stir for 15 min at RT. Solvent 
was removed under reduced pressure and the residue was triturated from 
dichloromethane/hexane solution (1/2 = V/V) to give 3-phenylprop-2-yn-1-amine hydrochloride 




Procedure for the synthesis of propargyl amine boranecarbonitrile 2. 
 
 
To a solution of propargyl amine hydrochloride 4.38 (50.0 mmol, 1.0 eq.) in tetrahydrofuran 
(250 mL, 0.2 M), was successively added MgSO4 (10.0 g), NaBH3CN (250.0 mmol, 5.0 eq.). 
The reaction mixture was stirred at refluxing for 24 hours. The reaction mixture was monitored 
by TLC. Upon completion, the solid precipitates was removed by filtration and washed with 
diethyl ether (3 × 10mL). The combined mixture was washed with brine (2 × 10mL) and solvent 
was removed under reduced pressure. The residue was purified by flash chromatography on 
silica gel (ethyl acetate/hexane = 1/2, V/V) to give 4.39 as white solid or colorless liquid. 
 




To a solution of 4.39 (0.2 mmol, 1.0 eq.) in 1,2-dichloroethane (5 mL, 0.04 M), was added 
XPhosAu(TA)OTf (9.3 mg, 5 mol %). The reaction mixture was stirred at 80 
o
C for 72 hours and 
monitored by TLC. Upon completion, solvent was removed under reduced pressure and the 
residue was purified by flash chromatography on silica gel (ethyl acetate/hexane = 1/2, V/V) to 
give 4.40 as white solid or colorless liquid. 
 





To a solution of 4.40 (0.5 mmol, 1.0 eq.) in tetrahydrofuran (12 mL, 0.04 M) at 0 
o
C, LiAlH4 was 
added (19 mg, 0.5 mmol, 1.0 eq.). The reaction mixture was stirred at 0 
o
C for 15 min and 
warmed to RT and stirred for 30 min, then the second portion of LiAlH4 was added (38 mg, 1.0 
mmol, 2.0 eq.). The reaction was monitored by TLC. Upon completion, solvent was removed 
under reduced pressure and the residue was purified by flash chromatography on silica gel (ethyl 
acetate/hexane = 1/2, V/V) to give 4.41a as white solid or 4.41b as colorless liquid. 
 
Procedure for phenyl substitution on boron center of 4a. 
 
 
To a solution of 4.40a (85 mg, 0.5 mmol, 1.0 eq.) in tetrahydrofuran (12 mL, 0.04 M) at 0 
o
C, 
PhMgBr (2.8 M solution in diethyl ether) was added (0.18 mL, 0.5 mmol, 1.0 eq.). The reaction 
mixture was stirred at 0 
o
C for 15 min and warmed to RT and stirred for 30 min, then the second 
portion of PhMgBr (2.8 M solution in diethyl ether) was added (0.36 mL, 1.0 mmol, 2.0 eq.) and 
stirred at RT. Reaction was monitored by TLC. Upon completion, solvent was removed under 
reduced pressure and the residue was purified by flash chromatography on silica gel (ethyl 







II. Condition Screening Data 
 
Table 1. Condition screening of amine borane 1 with typical and classic gold catalysts. 
 
entry Au catalyst time conv. (%) yield (%) 
1 PPh3AuCl/AgOTf 1 hr or 24 hr <5 n.d. 
2 IPrAuCl/AgOTf 1 hr or 24 hr <5 n.d. 
3 XPhosAuCl/AgOTf 1 hr or 24 hr <5 n.d. 








































 1 hr or 24 hr <5 n.d. 
 
General reaction conditions: entry 1-4, all Au catalyst was generated by mixing corresponding 
LAuCl (L = PPh3, IPr, XPhos, P(OMe)3) complexe with AgOTf (1.1 eq.) in CH2Cl2 (1 mL), the 
mixture was stirred for 5 minutes then filtered through cotton pad and added to a solution of 1 in 
CH2Cl2. RT = room temperature, n.d. = not determined. Conversion and yields were determined 



















1 CH2Cl2 rt 3 <5 n.d. 
2 CHCl3 rt 3 <5 n.d. 
3 MeOH rt 3 <5 n.d. 
4 DMF rt 3 <5 n.d. 
5 MeCN rt 3 <5 n.d. 
6 Et2O rt 1 <5 n.d. 
7 Et2O rt 3 47 25 
8 Et2O rt 5 92 43 
9 THF rt 1 <5 n.d. 
10 THF rt 5 11 trace 
11 THF reflux 1 23 9 
12 THF reflux 5 >99 87 
 
General reaction conditions: NaBH3CN, MgSO4 (600mg, 5 mmol 5.0 eq.).was suspended in 
solution and stirring at room temprature, 4.38b (195mg, 1 mmol, 1.0 eq.) was added slowly and 
the reaction mixture was let stirred at the indicated conditions. rt = room temperature, n.d. = not 








entry Au catalyst (5%) 
solvent T (
o




1 PPh3AuCl CH2Cl2 rt 72 hr <5 n.d. 
2 PPh3AuCl/AgOTf CH2Cl2 rt 30 min or72 hr 19 17 
3 IPrAuCl/AgOTf CH2Cl2 rt 30 min or72 hr 15 11 
4 XPhosAuCl/AgOTf CH2Cl2 rt 30 min or72 hr <5 n.d. 




















 CH2Cl2 rt 30 min or72 hr 16 2 
10 PPh3AuCl DCE 80 72 hr <5 n.d. 
11 XPhosAuCl/AgOTf DCE 80 30 min or72 hr 10 5 















































 MeCN 80 72 hr 88 65 
 
General reaction conditions: 4.39b (39 mg, 0.2 mmol 1.0 eq.), solvent (5 mL) and Au catalyst 
(0.01 mmol, 5 mol %).was successively added into 20 mL reaction vial and stirred at 
coorespounding temprature. rt = room temperature, n.d. = not determined, TA = 1H-









entry Au catalyst time per-catalyst (%) 
1 PPh3AuCl/AgOTf 
0 100 














1 hr 90 
20 hr 55 
4 XPhosAuCl/AgOTf 
0 100 





















1 hr 90 
20 hr 85 
 
A sealed capillary tube containing H3PO4/D2O (1M) solution was used as internal standard for 





III. ORTEP Drawing of the Crystal Structure 
 
 
Figure 1. Perspective view of the molecular structure of 4.39a (C10H11BN2) with the atom 
labeling scheme provided for the non-hydrogen atoms. The thermal ellipsoids are 




Figure 2.  Perspective view of the molecular structure of 4.40b (C12H15BN2) with the atom 






Figure 3.  Perspective view of the molecular structure of 4.42 (C16H15BN2) with the atom 






IV. Compounds Characterization 
 
 
4.34 was purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as light yellow liquid; 1H-
NMR (400 MHz, CDCl3) δ 4.15 (b, 3H), 3.56 (ddd, J = 9.2 Hz, 5.2 Hz, 2.4 Hz, 2H), 2.46 (t, J = 
2.0 Hz, 1H), 1.83-1.09 (b, 3H); 13C-NMR (100 MHz, CDCl3) δ 77.5, 75.1,  7.6; 11B-NMR (128 
MHz, CDCl3) -18.76; HRMS Calculated for C3H8BN [M+Na]+: 92.0647, Found: 92.0644. 
 
 
4.39a was purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as white solid with 97% 
yield; 1H-NMR (400 MHz, CD3CN) δ 7.47-7.44 (m, 2H), 7.41-7.36 (m, 3H), 5.03 (b, 2H), 3.69 
(t, J = 6.8 Hz, 2H), 2.15-1.24 (b, 2H); 13C-NMR (100 MHz, CD3CN) δ 1 6.8, 1 4. , 1  .9, 
127.2, 90.9, 87.8, 41.2; 11B-NMR (128 MHz, CD3CN) -18.20; HRMS Calculated for 
C10H11BN2 [M+Na]+: 193.0907, Found: 193.0909. 
 
 
4.39b was purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as yellow liquid with 87%; 
1H-NMR (400 MHz, CDCl3) δ 7.46-7.44 (m, 2H), 7.37-7.31 (m, 3H), 5.25 (b, 1H), 3.99 (dd, J = 
11.2 Hz, 2.4 Hz, 1H), 3.72 (dd, J = 11.2 Hz, 5.2 Hz, 1H), 3.25-3.19 (m, 1H), 3.09-3.02 (m, 1H), 
2.23-1.56 (b, 2H), 1.32 (t, J = 4.8 Hz, 3H); 13C-NMR (100 MHz, CDCl3) δ 1 1.8, 129.1, 128.4, 
121.6, 87.9, 80.0, 46.9, 42.7, 10.8; 11B-NMR (128 MHz, CDCl3) -20.45; HRMS Calculated for 





4.39c was purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as white solid with 89%; 
1H-NMR (400 MHz, CDCl3) δ 7.47-7.44 (m, 2H), 7.32-7.24 (m, 3H), 5.03 (b, 1H), 4.87 (b, 1H), 
3.83-3.76 (m, 1H), 1.99-1.90 (m, 1H), 1.83-1.74 (m, 1H),1.05 (t, J = 7.2 Hz, 3H); 13C-NMR 
(100 MHz, CD3CN) δ 1 1.7, 128.7, 128.2, 121.8, 87.2, 84.6, 51.0, 26.9, 9.6; 11B-NMR (128 




4.39d was purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as light yellow liquid with 
81% yield; 1H-NMR (400 MHz, CDCl3) δ 6.16 (t,   = 2.0 Hz, 1H), 4.75 (b, 2H),  .69 (t,   = 6.4 
Hz, 2H), 2.10-2.07 (m, 4H), 1.66-1.55 (m, 4H); 13C-NMR (100 MHz, CDCl3) δ 1 7.0, 119.4, 
78.7, 60.5, 37.0, 28.7, 25.6, 22.0, 21.3; 11B-NMR (128 MHz, CDCl3) -22.68; HRMS Calculated 
for C10H15BN2 [M+Na]+: 197.1221, Found: 197.1218. 
 
 
4.39e was purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as light yellow liquid with 
73% yield; 1H-NMR (400 MHz, CDCl3) δ 4.86 (b, 2H),  .55-3.50 (m, 2H), 2.79-1.17 (b, 2H), 
1.85 (t, J = 2.4 Hz, 3H); 13C-NMR (100 MHz, CDCl3) δ 8 .9, 72.0,  6.5,  .5; 11B-NMR (128 





4.39f was purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as light yellow liquid with 
91% yield; 1H-NMR (400 MHz, CDCl3) δ 4.8  (b, 1H),  .72 (dt,   = 16.4 Hz, 2.8 Hz, 1H),  .42 
(ddd, J = 16.4 Hz, 4.8 Hz, 2.0 Hz, 1H), 3.05-3.00 (m, 1H), 2.87-2.79 (m, 1H), 1.84 (t, J = 2.4 Hz, 
3H), 1.69-1.61 (m, 2H), 1.38-1.29 (m, 2H), 0.94 (t, J = 7.6 Hz, 3H); 13C-NMR (100 MHz, 
CDCl3) δ 84.6, 70. , 51.8, 4 .1, 27.4, 19.9, 1 .5,  .5; 11B-NMR (128 MHz, CDCl3) -20.29; 
HRMS Calculated for C9H17BN2 [M+Na]+: 187.1377, Found: 187.1379. 
 
 
4.39g was purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as light yellow liquid with 
83% yield; 1H-NMR (400 MHz, CDCl3) δ 4.81 (b, 2H), 3.49 (td, J = 7.2 Hz, 2.0 Hz, 2H), 2.28-
1.31 (b, 2H), 1.27-1.20 (m, 1H), 0.84-0.73 (m, 2H), 0.72-0.67 (m, 2H); 13C-NMR (100 MHz, 
CDCl3) δ 91. , 68.0,  6.6, 8.2, -0.8; 11B-NMR (128 MHz, CDCl3) -25.77; HRMS Calculated for 
C7H11BN2 [M+Na]+: 157.0912, Found: 157.0908. 
 
 
4.39h was purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as light yellow liquid with 
66% yield; 1H-NMR (400 MHz, CDCl3) δ 5.02 (b, 2H),  .47 (ddd,   = 1 .6 Hz, 6.8 Hz, 2.8 Hz, 
2H), 2.72 (t, J = 2.8 Hz, 1H), 2.03-1.05 (b, 2H); 13C-NMR (100 MHz, CDCl3) δ 82. , 80. , 40. ; 






4.39i was purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as light yellow liquid with 
85% yield; 1H-NMR (400 MHz, CDCl3) δ 5.47 (b, 1H),  .70 (dt,   = 17.2 Hz,  .6 Hz, 1H),  .46 
(ddd, J = 16.8 Hz, 7.2 Hz, 2.4 Hz, 1H), 3.03-2.95 (m, 1H), 2.86-2.79 (m, 1H), 2.45 (t, J = 2.4 Hz, 
1H), 1.84 (t, J = 2.4 Hz, 3H), 1.66-1.58 (m, 2H), 1.34-1.27 (m, 2H), 0.91 (t, J = 7.2 Hz, 3H); 
13C-NMR (100 MHz, CDCl3) δ 76.4, 74.6, 51.7, 42.0, 27.1, 19.8, 1 .4; 11B-NMR (128 MHz, 
CDCl3) -20.29; HRMS Calculated for C8H15BN2 [M+Na]+: 173.1221, Found: 173.1227. 
 
 
4.39j was purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as light yellow solid with 
89% yield; 1H-NMR (400 MHz, CDCl3) δ 7. 6 (d,   = 8.8 Hz, 2H), 6.8  (d,   = 8.8 Hz, 2H), 
4.86 (b, 2H), 3.79 (s, 3H), 3.74 (t, J = 6.4 Hz, 2H), 2.33-1.46 (b, 2H); 13C-NMR (100 MHz, 
CDCl3) δ 160.2, 1  .4, 114.0, 11 .4, 87. , 80.2, 55. ,  7.1; 11B-NMR (128 MHz, CDCl3) -23.72; 
HRMS Calculated for C11H13BN2O [M+Na]+: 223.1018, Found: 223.1025. 
 
 
4.39k was purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as light yellow solid with 
90% yield; 1H-NMR (400 MHz, CD3CN) δ 7.55-7.49 (m, 1H), 7.05-6.97 (m, 2H), 5.13 (b, 2H), 
3.74 (t, J = 6.8 Hz, 2H), 2.20-1.23 (b, 2H); 13C-NMR (100 MHz, CD3CN) δ 169.7, 169.6, 167.2, 
167.0, 140.3, 140.2, 117.5, 117.4, 117.2, 112.1, 111.9, 109.9, 109.8, 109.7, 109.6, 109.4, 109.3, 
92.9, 83.4, 41.2; 11B-NMR (128 MHz, CD3CN) -23.47; HRMS Calculated for C10H9BF2N2 





4.40a was purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as white solid with 93% 
yield; 1H-NMR (400 MHz, CDCl3) δ 7.49-7.47 (m, 2H), 7.32 (t, J = 7.2 Hz, 2H), 7.23 (t, J = 7.2 
Hz, 1H), 6.06 (s, 1H), 5.80 (b, 1H), 4.22 (b, 1H), 3.96 (d, J = 14.8 Hz, 1H), 3.83-3.78 (m, 1H), 
3.57-2.41 (b, 1H); 13C-NMR (100 MHz, CDCl3) δ 1 7.9, 128.4, 127.2, 127.0, 122.2, 51.6; 11B-




4.40b was purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as white solid with 89% 
yield; 1H-NMR (400 MHz, CDCl3) δ 7.47 (d,   = 5.6 Hz, 2H), 7. 1 (t,   = 5.2 Hz, 2H), 7.22 (t,   
= 4.8 Hz, 1H), 6.10 (s, 1H), 4.33 (b, 1H), 3.97 (ddd, J = 9.6 Hz, 4.0 Hz, 1.6 Hz, 1H), 3.70 (dd, J 
= 9.6 Hz, 5.6 Hz, 1H), 3.37-3.32 (m, 1H), 3.15-3.09 (m, 1H), 1.36 (t, J = 5.2 Hz, 3H); 13C-NMR 
(100 MHz, CDCl3) δ 1 7.9, 128. , 127. , 126.9, 121. , 58.5, 46.5, 1 .1; 11B-NMR (128 MHz, 




4.40c was purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as white solid with 85% 
yield; 1H-NMR (400 MHz, CDCl3) δ 7.48 (d,   = 8.0 Hz, 2H), 7. 1 (t,   = 7.2 Hz, 2H), 7.23 (t, J 
= 7.2 Hz, 1H), 6.10 (s, 0.5H), 6.05 (s, 1H), 4.92 (s, 0.5H), 4.64 (s, 0.5H), 4.14 (q, J = 6.4 Hz, 
0.5H), 3.94 (q, J = 6.0 Hz, 0.5H), 3.56 (s, 0.5H), 3.37-2.43 (b, 1H), 1.75-1.51 (m, 3H), 0.98 (t, J 
= 7.2 Hz, 1.5H), 0.92 (t, J = 7.6 Hz, 1.5H); 13C-NMR (100 MHz, CDCl3) δ 1 8.1, 1 8.0, 128. , 
127.2, 127.1, 127.0, 126.9, 126.8, 126.7, 66.6, 65.9, 27.9, 27.8, 10.3, 9.9; 11B-NMR (128 MHz, 






4.40d was purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as light yellow liquid with 
77% yield; 1H-NMR (400 MHz, CD3CN) δ 5.80 (t,   = 4.0 Hz, 1H), 5.58 (s, 1H), 4.95 (b, 2H), 
3.81-3.76 (m, 1H), 3.69-3.67 (m, 1H), 2.20-2.11 (m, 4H), 1.69-1.64 (m, 2H), 1.61-1.56 (m, 2H); 
13C-NMR (100 MHz, CD3CN) δ 140.7, 1  .6, 125.5, 55.8,  1.1,  0.9, 27.9, 27.6; 11B-NMR 




4.40e was purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as light yellow liquid with 
63% yield; 1H-NMR (400 MHz, CDCl3) δ 5.55 (b, 1H), 5.41 (s, 1H), 4.2  (b, 1H),  .85-3.77 (m, 
1H), 3.70-3.63 (m, 1H), 3.01-2.07 (b, 1H), 1.83 (t, J = 2.4 Hz, 3H); 13C-NMR (100 MHz, CDCl3) 
δ121.8, 51.1, 16.7; 11B-NMR (128 MHz, CDCl3) -15.86; HRMS Calculated for C5H9BN2 
[M+Na]+: 131.0751, Found: 131.0755. 
 
 
4.40f was purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as light yellow liquid with 
81% yield; 1H-NMR (400 MHz, CDCl3) δ 5. 9 (s, 1H), 4. 7 (s, 1H),  .79-3.74 (m, 1H), 3.50-
3.43 (m, 1H), 3.21-3.12 (m, 1H), 2.99-2.91 (m, 1H), 1.78 (s, 3H), 1.74-1.62 (m, 2H), 1.38 (q, J = 
7.2 Hz, 2H), 0.97 (t, J = 6.0 Hz, 3H); 13C-NMR (100 MHz, CDCl3) δ 121. , 58.5, 54.4, 51.5, 
29.5, 19.8, 13.6; 11B-NMR (128 MHz, CDCl3) -11.22; dr = 3:1; HRMS Calculated for 





4.40g was purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as light yellow liquid with 
73% yield; 1H-NMR (400 MHz, CDCl3) δ5.59 (b, 1H), 5.50 (s, 1H), 4.19 (b, 1H),  .88-3.81 (m, 
1H), 3.70-3.65 (m, 1H), 2.91-1.97 (b, 1H) 1.63-1.57 (m, 1H), 0.75-0.57 (m, 4H); 13C-NMR (100 
MHz, CDCl3) δ 119.8, 51.0, 1 .8, 6. ; 11B-NMR (128 MHz, CDCl3) -14.84; HRMS Calculated 
for C7H11BN2 [M+Na]+: 157.0912, Found: 157.0908. 
 
 
4.40h was purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as light yellow liquid with 
89% yield; 1H-NMR (400 MHz, CDCl3) δ 6.01 (d,   = 8.0 Hz, 1H), 5.85 (d,   = 8.0 Hz, 1H), 
5.56 (b, 1H), 4.15 (b, 1H), 3.91-3.75 (m, 1H), 3.75-3.68 (m, 1H), 3.19-2.20 (b, 1H); 13C-NMR 
(100 MHz, CDCl3) δ128.9, 51.6; 11B-NMR (128 MHz, CDCl3) -13.42; HRMS Calculated for 
C4H7BN2 [M+Na]+: 117.0594, Found: 117.0587. 
 
 
4.40i was purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as light yellow liquid with 
90% yield; 1H-NMR (400 MHz, CDCl3) δ 6.08 (d,   = 7.6 Hz, 1H), 5.85 (d,   = 7.6 Hz, 1H), 
4.22 (s, 1H), 3.82 (dd, J = 14.0 Hz, 6.4 Hz, 1H), 3.54-3.48 (m, 1H), 3.26-3.17 (m, 1H), 3.05-2.95 
(m, 1H), 1.79-1.62 (m, 2H), 1.45-1.35 (m, 2H), 0.98 (t, J = 7.2 Hz, 3H); 13C-NMR (100 MHz, 
CDCl3) δ 128.6, 58.6, 51.4, 29.7, 19.8, 1 .6; 11B-NMR (128 MHz, CDCl3) -11.70; dr = 2:1; 





4.40j was purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as white solid with 43% 
yield; 1H-NMR (400 MHz, CD3CN) δ 7.40 (dd,   = 6.8 Hz, 2.4 Hz, 2H), 6.87 (dd,   = 9.6 Hz, 
2.4 Hz, 2H), 6.00 (s, 1H), 5.17-4.94 (b, 2H), 3.85-3.77 (m, 5H), 3.37-2.27 (b, 1H); 13C-NMR 
(100 MHz, CD3CN) δ 128.9, 121.9, 118. , 114.6, 111.0, 55.9, 55. ; 11B-NMR (128 MHz, 
CD3CN) -13.90; HRMS Calculated for C11H13BN2O [M+Na]+: 223.1018, Found: 223.1025. 
 
 
4.40k was purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as white solid with 80% 
yield; 1H-NMR (400 MHz, CDCl3) δ 7.52-7.37 (m, 1H), 6.87-6.77 (m, 2H), 6.30 (s, 1H), 5.59 (s, 
1H), 4.28 (s, 1H), 4.10-4.04 (m, 1H), 3.94-3.89 (m, 1H), 3.57-2.23 (b, 1H); 13C-NMR (100 MHz, 
CDCl3) δ 1 1.6, 126.4, 126. , 111.2, 111.1, 110.9, 110.8, 104. , 104.0, 10 .7, 51.8; 11B-NMR 




4.41a was purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as white solid with 73% 
yield; 1H-NMR (400 MHz, CDCl3) δ 7.47 (dd,   = 8.4 Hz, 1.2 Hz, 2H), 7.29 (tt,   = 7.6 Hz, 2.0 
Hz, 2H), 7.19 (tt, J = 7.6 Hz, 1.2 Hz, 1H), 5.98 (s, 1H), 4.08 (b, 2H), 3.86-3.81 (m, 2H), 3.23-
2.15 (b, 2H); 13C-NMR (100 MHz, CDCl3) δ 1 9.7, 128.2, 126.9, 126.6, 118.2, 51.9; 11B-NMR 






4.41b was purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as colorless liquid with 81% 
yield; 1H-NMR (400 MHz, CDCl3) δ 7.48 (dd,   = 8.8 Hz, 1.6 Hz, 2H), 7.29 (t,   = 7.2 Hz, 2H), 
7.18 (t, J = 7.6 Hz, 1H), 5.92 (s, 1H), 4.07 (b, 1H), 3.89 (dd, J = 14.8 Hz, 6.4 Hz, 1H), 3.47 (ddd, 
J = 12.0 Hz, 7.6 Hz, 2.4 Hz, 1H), 3.05-2.95 (m, 1H), 2.88-2.80 (m, 1H), 1.83 (t, J = 7.2 Hz, 3H); 
13C-NMR (100 MHz, CDCl3) δ 1 9.8, 128.1, 126.8, 126.5, 117.7, 58.8, 48.7, 1 .0; 11B-NMR 




4.42 was purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as white solid with 67% 
yield; 1H-NMR (400 MHz, CD3CN) δ 7.46 (dd,   = 8.4 Hz, 1.6 Hz, 2H), 7. 5 (dt, J = 8.0 Hz, 1.6 
Hz, 2H), 7.25 (tt, J = 6.4 Hz, 1.6 Hz, 2H), 7.19 (tt, J = 8.4 Hz, 1.6 Hz, 3H), 7.12 (tt, J = 6.8 Hz, 
1.6 Hz, 1H), 6.36 (s, 1H), 5.55 (b, 1H), 4.82 (b, 1H), 3.94-3.80 (m, 2H), 2.20 (s, 3H); 13C-NMR 
(100 MHz, CDCl3) δ 1 9.7, 1  .7, 129.0, 128.6, 127.9, 127.8, 127.6, 126.4, 50.8; 11B-NMR 
(128 MHz, CDCl3) -6.22; HRMS Calculated for C10H11BN2 [M+Na]+: 193.0913, Found: 
193.0917. 
 
